Link,ID,doc_name,has_clinical,Year,acute/sustained,sample group size,outcome count,disease,outcome direction,gnotobiotic,animal strain,animal sex,animal age value (days),animal age description,animal weight value (g),animal weight description,species,mechanism_of_action,disease model,intervention delivery,success measure,tested dose dependently,prophylactic / therapeutic,ribotype,c diff strain,c diff dose value,c diff dose units,c diff dose vegetative/spores,c diff dose description,daily dosage,total dosage,dosage value,dosage units,dosage times per day,dosage duration,dosage description,intervention,comparator,accute efficacy,sustained efficacy,comment,Done?,matched
https://pubmed.ncbi.nlm.nih.gov/30292822,30292822,30292822.txt,TRUE,2019,acute,7,2.8 (1.6 - 3.8),Clostridioides difficile infection,positive,axenic,N/A,N/A,0,0 days,N/A,N/A,pig,,challenge,,clinical score,F,p,14,283 (RT014/020),10000000,N/A,spores,10^7,1000000,1000000,10^6,spores,QD,1,,"Z31, a NTCD strain",control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30292822,30292822,30292822.txt,TRUE,2019,acute,7,6.8 (4.6 - 8.9),Clostridioides difficile infection,positive,axenic,N/A,N/A,0,0 days,N/A,N/A,pig,,challenge,,clinical score,F,p,14,283 (RT014/020),10000000,N/A,spores,10^7,,,,,,,,control,"Z31, a NTCD strain",equivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/77366,77366,77366.txt,TRUE,1978,acute,4,4,C. difficile,positive,N/A,Golden Syrian,N/A,42,1-2 months,N/A,N/A,hamster,,challenge,clindamycin+challenge,death from enterocolitis,F,p,,NA,13,CFU,N/A,13,,,,,,,,Negative Control,Negative Control,inferior,NA,"pretreatment with vancomycin, 3mg/ml in water for 1 week until 2-3 days before expt, more data with different strains",Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/77366,77366,77366.txt,TRUE,1978,acute,4,0,C. difficile,positive,N/A,Golden Syrian,N/A,42,1-2 months,N/A,N/A,hamster,,challenge,clindamycin+challenge,death from enterocolitis,F,p,,NA,13,CFU,N/A,13,3,N/A,3,mg/ml,,7,,vancomycin,Negative Control,inferior,NA,"pretreatment with vancomycin, 3mg/ml in water for 1 week until 2-3 days before expt, more data with different strains",Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,101.8 (100.6 - 103.0)%,Clostridium difficile infection,positive,N/A,C57BL/6,F,70,10 weeks,20,20g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,% initial body weight,F,t,87,VPI 10463,100,N/A,spores,~100,40,80,20,mg/kg,BID,2,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,87.9 (87.2 - 88.9)%,Clostridium difficile infection,positive,N/A,C57BL/6,F,70,10 weeks,20,20g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,% initial body weight,F,t,87,VPI 10463,100,N/A,spores,~100,,,,,,,,Negative Control,vancomycin 20mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26917573,26917573,26917573.txt,TRUE,2016,acute,13,6,Clostridium difficile infection,positive,N/A,C57BL/6,M,504,18 months,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,,,,,,,,old control,vancomycin 50 mg/kg,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26917573,26917573,26917573.txt,TRUE,2016,acute,8,8,Clostridium difficile infection,positive,N/A,C57BL/6,M,504,18 months,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,old control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26917573,26917573,26917573.txt,TRUE,2016,sustained,8,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,504,18 months,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,old control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26917573,26917573,26917573.txt,TRUE,2016,acute,13,7,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,2 months,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,,,,,,,,young control,vancomycin 50 mg/kg,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26917573,26917573,26917573.txt,TRUE,2016,acute,8,8,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,2 months,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,young control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26917573,26917573,26917573.txt,TRUE,2016,sustained,8,8,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,2 months,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,young control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33305657,33305657,33305657.txt,TRUE,2020,acute,12,12,Clostridioides difficile,positive,N/A,C57BL/6,N/A,84,2-4 months,N/A,N/A,mouse,,neomycin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,1000,N/A,spores,1000,1000,1000,10^3,spores,QD,1,,NTCD-035,Negative Control,superior,NA,"made up numbers, proportions are correct",Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33305657,33305657,33305657.txt,TRUE,2020,acute,12,4,Clostridioides difficile,positive,N/A,C57BL/6,N/A,84,2-4 months,N/A,N/A,mouse,,neomycin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,1000,N/A,spores,1000,,,,,,,,Negative Control,NTCD-035,superior,NA,"made up numbers, proportions are correct",Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/21537099,21537099,21537099.txt,TRUE,2011,acute,10,"mean 5.64, sd 0.46217, range 5-6.4, median 5.55",Clostridium difficile-associated disease (CDAD),positive,N/A,BALB/c,M,35,4-6 weeks,25,25g,mouse,,ampicillin+challenge,,log10 CFU /ml,F,p,5,ATCC 43594,100000000,CFU,N/A,10^8,1000000,7000000,10^6,CFU/ml,QD,7,10^6 CFU/ml for 7 days,Lactobacillus acidophilus,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/21537099,21537099,21537099.txt,TRUE,2011,acute,10,"mean 0.5, sd 0.54772, range 0 - 1.0, median 0.5",Clostridium difficile-associated disease (CDAD),positive,N/A,BALB/c,M,35,4-6 weeks,25,25g,mouse,,challenge,,log10 CFU /ml,F,t,5,ATCC 43594,100000000,CFU,N/A,10^8,1000000,7000000,10^6,CFU/ml,QD,7,10^6 CFU/ml for 7 days,Lactobacillus acidophilus,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/21537099,21537099,21537099.txt,TRUE,2011,acute,10,"mean 5.6633, sd 0.56092, range 5 - 6.3, median 5.82",Clostridium difficile-associated disease (CDAD),positive,N/A,BALB/c,M,35,4-6 weeks,25,25g,mouse,,ampicillin+challenge,,log10 CFU /ml,F,p,5,ATCC 43594,100000000,CFU,N/A,10^8,,,,,,,,control,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/21537099,21537099,21537099.txt,TRUE,2011,acute,10,"4.1833, SD 0.51153, 3.4 - 4.9, median 4.15",Clostridium difficile-associated disease (CDAD),positive,N/A,BALB/c,M,35,4-6 weeks,25,25g,mouse,,challenge,,log10 CFU /ml,F,t,5,ATCC 43594,100000000,CFU,N/A,10^8,,,,,,,,control,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,4,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.3,1.5,0.3,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,3,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.3,1.5,0.3,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,10,50,10,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,100,500,100,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,12.5,62.5,12.5,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,12.5,62.5,12.5,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,25,125,25,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,25,125,25,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,3,15,3,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,3,15,3,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,30,150,30,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,30,150,30,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/9839563,9839563,9839563.txt,TRUE,1997,,8,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,toxin A,,Inflamation of ileal mucus,F,p,,ME 82,,,,,,,,,,,,cefoxitin,Positive control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9839563,9839563,9839563.txt,TRUE,1997,,8,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,toxin A,,Inflamation of ileal mucus,F,p,,ME 82,,,,,,,,,,,,cefoxitin,Toxin A (negative) control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9839563,9839563,9839563.txt,TRUE,1997,,5,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,toxin A,,Inflamation of ileal mucus,F,p,,VPI 10463,,,,,,,,,,,,ampicilin+Lactobacillus rhamnosus + xylitol,Toxin A (negative) control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,300,1500,300,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,300,1500,300,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,50,250,50,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,50,250,50,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,30,2,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,2,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.3,1.5,0.3,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.3,1.5,0.3,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,4,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,10,50,10,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,8,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,100,500,100,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,4,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,12.5,62.5,12.5,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,3,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,12.5,62.5,12.5,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,6,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,25,125,25,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,,NA,,C. difficile disease,positive,,Wistar,M,,,,,rat,,ileal loop + toxin A,,inhibiting Vero cell protein synthesis,T,t,,NA,,,,,,,,,,,,GT160-246,Cholestyramine,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,,NA,,C. difficile disease,positive,,Wistar,M,,,,,rat,,ileal loop + toxin B,,inhibiting Vero cell protein synthesis,T,t,,NA,,,,,,,,,,,,GT160-246,Cholestyramine,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,20,1,C. difficile disease,positive,,NA,NA,,,,,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,,,,,,,,,,,,saline control,Saline (control),superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,4,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,25,125,25,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,2,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,3,15,3,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,6,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,3,15,3,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,20,10,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,30,150,30,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,20,1,C. difficile disease,positive,,NA,NA,,,,,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,,,,,,,,,,,,saline control,Saline (control),superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,8,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,30,150,30,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,6,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,300,1500,300,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,8,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,300,1500,300,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,10,4,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,50,250,50,mg/kg,QD,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,50,250,50,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,30,2,C. difficile disease,positive,N/A,Golden Syrian,M,58,45-70 days,111,98-124g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23689716,23689716,23689716.txt,TRUE,2013,acute,8,2,C. difficile disease,positive,axenic,N/A,N/A,5,5 days,N/A,N/A,pig,,challenge,,cumulative mortality,T,t,27,UK6,1000000,N/A,spores,10^6,,,,,,,,control,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23689716,23689716,23689716.txt,TRUE,2013,acute,9,8,C. difficile disease,positive,axenic,N/A,N/A,5,5 days,N/A,N/A,pig,,challenge,,cumulative mortality,T,t,27,UK6,1000000,N/A,spores,10^6,200,1400,100,mg/kg,BID,7,,MBX-500,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23689716,23689716,23689716.txt,TRUE,2013,acute,4,3,C. difficile disease,positive,axenic,N/A,N/A,5,5 days,N/A,N/A,pig,,challenge,,cumulative mortality,T,t,27,UK6,1000000,N/A,spores,10^6,400,2800,200,mg/kg,BID,7,,MBX-500,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23689716,23689716,23689716.txt,TRUE,2013,acute,6,6,C. difficile disease,positive,axenic,N/A,N/A,5,5 days,N/A,N/A,pig,,challenge,,cumulative mortality,T,t,27,UK6,1000000,N/A,spores,10^6,800,5600,400,mg/kg,BID,7,,MBX-500,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23689716,23689716,23689716.txt,TRUE,2013,acute,4,4,C. difficile disease,positive,axenic,N/A,N/A,5,5 days,N/A,N/A,pig,,challenge,,cumulative mortality,T,t,27,UK6,1000000,N/A,spores,10^6,40,280,20,mg/kg,BID,7,,vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,acute,6,98 (96-100)%,Clostridioides difficile,positive,N/A,C57BL/6J,M/F,35,5 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,weight loss,F,t,12,630,100000,CFU,spores,10^5,5,25,5,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,acute,6,99 (98-100)%,Clostridioides difficile,positive,N/A,C57BL/6J,M/F,35,5 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,weight loss,F,t,12,630,100000,CFU,spores,10^5,,,,,,,,Negative Control,vancomycin 0.4 mg/ml @ day 4,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,sustained,6,87 (83 - 91)%,Clostridioides difficile,positive,N/A,C57BL/6J,M/F,35,5 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,weight loss,F,t,12,630,100000,CFU,spores,10^5,5,25,5,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,sustained,6,103 (102-105)%,Clostridioides difficile,positive,N/A,C57BL/6J,M/F,35,5 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,weight loss,F,t,12,630,100000,CFU,spores,10^5,,,,,,,,Negative Control,vancomycin 0.4 mg/ml @ day 4,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33785619,33785619,33785619.txt,TRUE,2021,acute,4,"80.9,82.5,83.6,83.9",Clostridioides difficile,positive,SPF,C57BL/6,M/F,60,5-12 weeks,N/A,N/A,mouse,,clindamycin+challenge,clindamycin+challenge,weight loss,F,p,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,Negative Control,Strain 630,equivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16143709,16143709,16143709.txt,TRUE,2005,acute,8,,C. difficile disease,positive,,Golden Syrian,M,,,,,hamster,,challenge+clindamycin,,log10 CFU / g caecal contents spores,F,t,,421,,,,,,,,,,,,untreated control,control,superior,superior,no data for control past t0,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/16143709,16143709,16143709.txt,TRUE,2005,acute,23,"0,3.6,2.4,2.1",C. difficile disease,positive,,Golden Syrian,M,,,,,hamster,,challenge+clindamycin,,log10 CFU / g caecal contents spores,F,t,,421,,,,,,,,,,,50 mg/kg QD for 5 days,vancomycin,control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/16143709,16143709,16143709.txt,TRUE,2005,acute,23,"0,0,0,0",C. difficile disease,positive,,Golden Syrian,M,,,,,hamster,,challenge+clindamycin,,log10 CFU / g caecal contents spores,F,t,,421,,,,,,,,,,,50 mg/kg QD for 5 days,ramoplanin,control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33785619,33785619,33785619.txt,TRUE,2021,acute,7,"95.1,96.0,96.0,95.8,100,103.5,104.7",Clostridioides difficile,positive,SPF,C57BL/6,M/F,60,5-12 weeks,N/A,N/A,mouse,,clindamycin+challenge,clindamycin+challenge,weight loss,F,p,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,Strain 630,Negative Control,equivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.04,0.2,0.04,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.04,0.2,0.04,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,3,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,10,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,1,5,1,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,5,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,1,5,1,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,10,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,5,25,5,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,10,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,5,25,5,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,acute,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,,,,,,,,vehicle control,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.04,0.2,0.04,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.04,0.2,0.04,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,3,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,1,5,1,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,5,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,1,5,1,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,9,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,5,25,5,mg/kg,QD,5,,fidaxomicin,1 mg/kg vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,9,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,5,25,5,mg/kg,QD,5,,vancomycin,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,sustained,10,0,Clostridioides difficile,positive,SPF,Golden Syrian,M,39,5-6 weeks,N/A,N/A,hamster,,challenge+clindamycin,challenge+clindamycin,survival,T,t,87,VPI 10463,1000000,CFU,N/A,10^6,,,,,,,,vehicle control,1 mg/kg fidaxomicin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,acute,10,9,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,39,5-6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,50,250,50,mg/kg,QD,5,,vancomycin,untreated control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/17206941,17206941,17206941.txt,TRUE,2006,,10,,C. difficile disease,positive,,NA,NA,,,,,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,NA,,,,,,,,,,,,tolevamer,control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/17206941,17206941,17206941.txt,TRUE,2006,,10,,C. difficile disease,positive,,NA,NA,,,,,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,NA,,,,,,,,,,,,metronidazole,control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/17206941,17206941,17206941.txt,TRUE,2006,,10,,C. difficile disease,positive,,NA,NA,,,,,rat,,ileal loop + toxin A,,cumulative mortality,F,t,,NA,,,,,,,,,,,,tolevamer,control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/17206941,17206941,17206941.txt,TRUE,2006,,10,,C. difficile disease,positive,,NA,NA,,,,,rat,,ileal loop + toxin A,,cumulative mortality,F,t,,NA,,,,,,,,,,,,tolevamer,cholestyramine,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/17206941,17206941,17206941.txt,TRUE,2006,,10,,C. difficile disease,positive,,NA,NA,,,,,rat,,ileal loop + toxin A,,cumulative mortality,F,t,,NA,,,,,,,,,,,,cholestyramine,control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/17206941,17206941,17206941.txt,TRUE,2006,,10,,C. difficile disease,positive,,NA,NA,,,,,rat,,ileal loop + toxin A,,cumulative mortality,F,t,,NA,,,,,,,,,,,,cholestyramine,tolevamer,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,acute,10,2,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,39,5-6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,,,,,,,,untreated control,vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,sustained,10,3,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,39,5-6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,50,250,50,mg/kg,QD,5,,vancomycin,untreated control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,sustained,10,2,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,39,5-6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,,,,,,,,untreated control,vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26461425,26461425,26461425.txt,TRUE,2015,acute,10,8,Clostridium difficile,positive,N/A,C57BL/6,F,39,5-6 weeks,N/A,N/A,mouse,,"ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,p,27,UK6,10000000,N/A,spores,10^7,2000000,4000000,10^6,vegetative cells,BID,2,,Clostridium difficile CD37,control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26461425,26461425,26461425.txt,TRUE,2015,acute,10,2,Clostridium difficile,positive,N/A,C57BL/6,F,39,5-6 weeks,N/A,N/A,mouse,,"ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,p,27,UK6,10000000,N/A,spores,10^7,,,,,,,,control,Clostridium difficile CD37,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25547352,25547352,25547352.txt,TRUE,2015,acute,10,0 (error high 0),Clostridium difficile.,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU / g caecal content,F,p,12,630,500,N/A,spores,500,0.4,2,0.4,mg/ml,,5,0.4 mg/ml for 5 days,vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25547352,25547352,25547352.txt,TRUE,2015,acute,10,9.8e6 (error high 2.5e7),Clostridium difficile.,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU / g caecal content,F,p,12,630,500,N/A,spores,500,12.5,62.5,6.25,mg/kg,BID,5,,tigecycline,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25547352,25547352,25547352.txt,TRUE,2015,acute,10,1.2e8 (error high 2.3e8),Clostridium difficile.,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU / g caecal content,F,p,12,630,500,N/A,spores,500,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25547352,25547352,25547352.txt,TRUE,2015,sustained,10,3.3e7 (error high 1.1e8),Clostridium difficile.,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU / g caecal content,F,p,12,630,500,N/A,spores,500,0.4,2,0.4,mg/ml,,5,0.4 mg/ml for 5 days,vancomycin,tigecycline,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25547352,25547352,25547352.txt,TRUE,2015,sustained,10,1.3e8 (error high 1.6e8),Clostridium difficile.,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU / g caecal content,F,p,12,630,500,N/A,spores,500,12.5,62.5,6.25,mg/kg,BID,5,,tigecycline,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25547352,25547352,25547352.txt,TRUE,2015,sustained,10,1.7e8 (error high 3.5e8),Clostridium difficile.,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU / g caecal content,F,p,12,630,500,N/A,spores,500,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26169276,26169276,26169276.txt,TRUE,2015,acute,6,509 (9 to 8877),Recurrent Clostridium difficile infection,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU /g sample,F,t,12,630,1000,CFU,spores,1000,0.4,2,0.4,mg/ml,,5,0.4 mg over 5 days,vancomycin,control,equivalent,inferior,sample sizes may be off on control,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26169276,26169276,26169276.txt,TRUE,2015,acute,6,4.34e7 (8.53e6 to 1.68e8),Recurrent Clostridium difficile infection,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU /g sample,F,t,12,630,1000,CFU,spores,1000,,,,,,,,control,vancomycin,equivalent,inferior,sample sizes may be off on control,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26169276,26169276,26169276.txt,TRUE,2015,sustained,62,1.17e8 (8.88e7 to 1.61e8),Recurrent Clostridium difficile infection,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU /g sample,F,t,12,630,1000,CFU,spores,1000,0.4,2,0.4,mg/ml,,5,0.4 mg over 5 days,vancomycin,control,superior,superior,sample sizes may be off on control,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26169276,26169276,26169276.txt,TRUE,2015,sustained,23,1.96e2 (1.67 to 4.90e3),Recurrent Clostridium difficile infection,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge+vancomycin,,CFU /g sample,F,t,12,630,1000,CFU,spores,1000,,,,,,,single on 1 day or twice on 2 days,FMT,control,superior,superior,sample sizes may be off on control,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26169276,26169276,26169276.txt,TRUE,2015,sustained,62,3.04e7 (1.55e7 to 5.30e7),Recurrent Clostridium difficile infection,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,CFU /g sample,F,t,12,630,1000,CFU,spores,1000,,,,,,,,control,vancomycin,superior,superior,sample sizes may be off on control,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26169276,26169276,26169276.txt,TRUE,2015,sustained,5,1.34e7 (1.10e6 to 9.57e7),Recurrent Clostridium difficile infection,positive,N/A,C57BL/6,M/F,46,5-8 weeks,N/A,N/A,mouse,,cefoperazone+challenge+vancomycin,,CFU /g sample,F,t,12,630,1000,CFU,spores,1000,,,,,,,,control,FMT,superior,superior,sample sizes may be off on control,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,acute,11,8,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,100,500,50,mg/kg,BID,5,,MDX ,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,acute,11,11,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,100,500,50,mg/kg,BID,5,,UCB,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,acute,11,8,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,10,50,5,mg/kg,BID,5,,MDX ,UCB,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,acute,11,11,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,10,50,5,mg/kg,BID,5,,UCB,MDX ,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,10,50,5,mg/kg,BID,5,,Vancomycin,Negative Control,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,sustained,11,2,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,100,500,50,mg/kg,BID,5,,MDX ,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,sustained,11,8,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,100,500,50,mg/kg,BID,5,,UCB,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,sustained,11,1,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,10,50,5,mg/kg,BID,5,,MDX ,UCB,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,sustained,11,0,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,10,50,5,mg/kg,BID,5,,UCB,MDX ,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23324518,23324518,23324518.txt,TRUE,2013,sustained,5,0,C. difficile disease,positive,N/A,Golden Syrian,M,54,54 days,93,82-103g,hamster,antibody,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,3400000,CFU,vegetative,3.4x10^6,10,50,5,mg/kg,BID,5,,Vancomycin,Negative Control,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,10,10,Clostridium difficile infection,positive,N/A,Golden Syrian,F,42,6 weeks,100,100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,F,t,12,630,100,N/A,spores,100,10,50,5,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,10,1,Clostridium difficile infection,positive,N/A,Golden Syrian,F,42,6 weeks,100,100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,F,t,12,630,100,N/A,spores,100,,,,,,,,Negative Control,vancomycin 5 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,cyclosporin,control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,cyclosporin,epidermal growth factor + cyclosporin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,cyclosporin,probiotic + epidermal growth factor + cyclosporin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,epidermal growth factor + cyclosporin,control,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,epidermal growth factor + cyclosporin,epidermal growth factor + cyclosporin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,epidermal growth factor + cyclosporin,probiotic + epidermal growth factor + cyclosporin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,probiotic + epidermal growth factor + cyclosporin,control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,probiotic + epidermal growth factor + cyclosporin,cyclosporin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/20074161,20074161,20074161.txt,TRUE,2010,,24,,C. difficile disease,positive,,BALB/c,NA,,,,,mouse,,clindamycin+challenge,,change in weight,F,t,,NA,,,,,,,,,,,,probiotic + epidermal growth factor + cyclosporin,epidermal growth factor + cyclosporin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,RBx 11760,Positive Control,equivalent,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,RBx 11760,Vancomycin,superior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,RBx 11760,metronidazole,superior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,Vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,Vancomycin,RBx 11760,inferior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,Vancomycin,metronidazole,superior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,metronidazole,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,metronidazole,RBx 11760,inferior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393140,21393140,21393140.txt,TRUE,2011,,6,,C. difficile disease,positive,,Golden Syrian,NA,,,,,hamster,,Toxin A/B,,Level of Toxin A/B,F,t,12,ATCC 43596,,,,,,,,,,,,metronidazole,Vancomycin,inferior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,sustained,10,4,Clostridium difficile infection,positive,N/A,Golden Syrian,F,42,6 weeks,100,100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,F,t,12,630,100,N/A,spores,100,10,50,5,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,sustained,10,1,Clostridium difficile infection,positive,N/A,Golden Syrian,F,42,6 weeks,100,100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,F,t,12,630,100,N/A,spores,100,,,,,,,,Negative Control,vancomycin 5 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,acute,8,6,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,1,5,0.5,mg/kg,BID,5,,REP3123,Vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,acute,8,5,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,1,5,0.5,mg/kg,BID,5,,Vancomycin,REP3123,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,acute,8,7,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,10,50,5,mg/kg,BID,5,,REP3123,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,10,50,5,mg/kg,BID,5,,Vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,acute,8,0,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,,,,,,,,control,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,sustained,8,5,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,1,5,0.5,mg/kg,BID,5,,REP3123,Vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,sustained,8,5,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,1,5,0.5,mg/kg,BID,5,,Vancomycin,REP3123,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,sustained,8,6,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,10,50,5,mg/kg,BID,5,,REP3123,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/21576341,21576341,21576341.txt,TRUE,2011,acute,10,9,Recurrent C. difficile infection,positive,N/A,C57BL/6,NA,,5-6 weeks,,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,T,t,27,UK1,,,,10^6,,,50,mg/kg,BID,9,50 mg/kg BID for 9 days,vancomycin,control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/21576341,21576341,21576341.txt,TRUE,2011,sustained,10,5,Recurrent C. difficile infection,positive,N/A,C57BL/6,NA,,5-6 weeks,,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,T,t,27,UK1,,,,10^6,,,50,mg/kg,BID,9,50 mg/kg BID for 9 days,vancomycin,control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,sustained,8,0,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,10,50,5,mg/kg,BID,5,,Vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/19251726,19251726,19251726.txt,TRUE,2009,sustained,8,0,C. difficile disease,positive,N/A,Golden Syrian,M,42,6 weeks,99,89-109g,hamster,methionyl-tRNA synthetase inhibitor,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,16000000,CFU,vegetative,1.6x10^7,,,,,,,,control,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,0,Clostridioides difficile infection,positive,N/A,C57BL/6,F,42,6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,T,t,87,VPI 10463,800000,CFU,spores,8x10^5,1,6,1,mg/kg,QD,6,,metronidazole,control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,6,Clostridioides difficile infection,positive,N/A,C57BL/6,F,42,6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,T,t,87,VPI 10463,800000,CFU,spores,8x10^5,10,60,10,mg/kg,QD,6,,metronidazole,vancomycin 10 mg/kg,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,10,Clostridioides difficile infection,positive,N/A,C57BL/6,F,42,6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,T,t,87,VPI 10463,800000,CFU,spores,8x10^5,10,60,10,mg/kg,QD,6,,vancomycin,control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,2,Clostridioides difficile infection,positive,N/A,C57BL/6,F,42,6 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,T,t,87,VPI 10463,800000,CFU,spores,8x10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,14,Clostridioides difficile infection,positive,N/A,C57BL/6,F,46,6-7 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,27,R20291,8000,CFU,vegetative,8x10^3,,,,,,,,FMT-FD,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,11,Clostridioides difficile infection,positive,N/A,C57BL/6,F,46,6-7 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,27,R20291,8000,CFU,vegetative,8x10^3,,,,,,,,FMT-G10,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,12,Clostridioides difficile infection,positive,N/A,C57BL/6,F,46,6-7 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,27,R20291,8000,CFU,vegetative,8x10^3,,,,,,,,FMT-G80,Positive Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,10,2,Clostridioides difficile infection,positive,N/A,C57BL/6,F,46,6-7 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,27,R20291,8000,CFU,vegetative,8x10^3,,,,,,,,Negative Control,FMT-G10,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23939887/,23939887,23939887.txt,TRUE,2013,acute,10,10,Clostridium difficile,positive,N/A,Golden Syrian,M,49,6-8 weeks,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,mortality,F,p,27,BI1,100,CFU,spores,100,1000000,,10^6,CFU of spores,QD,1,,"M3, a NTCD strain",control,,,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23939887/,23939887,23939887.txt,TRUE,2013,acute,10,10,Clostridium difficile,positive,N/A,Golden Syrian,M,49,6-8 weeks,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,mortality,F,p,27,BI1,100,CFU,spores,100,1000000,,10^6,CFU of spores,QD,1,,"T7, a NTCD strain",control,,,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23939887/,23939887,23939887.txt,TRUE,2013,acute,2,0,Clostridium difficile,positive,N/A,Golden Syrian,M,49,6-8 weeks,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,mortality,F,p,27,BI1,100,CFU,spores,100,,,,,,,,control,,,,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23939887/,23939887,23939887.txt,TRUE,2013,sustained,10,9,Clostridium difficile,positive,N/A,Golden Syrian,M,49,6-8 weeks,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,mortality,F,p,27,BI1,100,CFU,spores,100,1000000,1000000,10^6,CFU of spores,QD,1,,"M3, a NTCD strain",control,,,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23939887/,23939887,23939887.txt,TRUE,2013,sustained,10,8,Clostridium difficile,positive,N/A,Golden Syrian,M,49,6-8 weeks,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,mortality,F,p,27,BI1,100,CFU,spores,100,1000000,1000000,10^6,CFU of spores,QD,1,,"T7, a NTCD strain",control,,,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23939887/,23939887,23939887.txt,TRUE,2013,sustained,2,0,Clostridium difficile,positive,N/A,Golden Syrian,M,49,6-8 weeks,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,mortality,F,p,27,BI1,100,CFU,spores,100,,,,,,,,control,,,,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,4,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,10,50,10,mg/kg,QD,5,,actoxumab-bezlotoxumab,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,4,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,2,10,2,mg/kg,QD,5,,actoxumab-bezlotoxumab,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,5,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,t,27,UK1,100000,N/A,spores,10^5,5,25,5,mg/kg,QD,5,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,4,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,50,250,50,mg/kg,QD,5,,actoxumab-bezlotoxumab,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22644020,22644020,22644020.txt,TRUE,2012,,NA,,C. difficile disease,positive,,Golden Syrian,M,,,,,hamster,,clindamycin+challenge,,cumulative mortality,F,t,87,VPI 10463,,,,,,,,,,,,LFF571,Control (saline),superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22644020,22644020,22644020.txt,TRUE,2012,,NA,,C. difficile disease,positive,,Golden Syrian,M,,,,,hamster,,clindamycin+challenge,,cumulative mortality,F,t,87,VPI 10463,,,,,,,,,,,,LFF571,vancomycin,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,50,50,50,mg/kg,QD,1,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,5,5,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,t,27,UK1,100000,N/A,spores,10^5,50,50,50,mg/kg,QD,1,,actoxumab-bezlotoxumab,N297Q mutant actoxumab-bezlotoxumab,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,50,50,50,mg/kg,QD,1,,N297Q mutant actoxumab-bezlotoxumab,N297Q mutant actoxumab-bezlotoxumab,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,10,2,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,,,,,,,,control,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,15,8,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,10,1,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,t,27,UK1,100000,N/A,spores,10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,4,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,10,50,10,mg/kg,QD,5,,actoxumab-bezlotoxumab,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,4,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,2,10,2,mg/kg,QD,5,,actoxumab-bezlotoxumab,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,5,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,t,27,UK1,100000,N/A,spores,10^5,5,25,5,mg/kg,QD,5,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,50,50,50,mg/kg,QD,1,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,5,5,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,t,27,UK1,100000,N/A,spores,10^5,50,50,50,mg/kg,QD,1,,actoxumab-bezlotoxumab,N297Q mutant actoxumab-bezlotoxumab,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,50,50,50,mg/kg,QD,1,,N297Q mutant actoxumab-bezlotoxumab,N297Q mutant actoxumab-bezlotoxumab,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,4,4,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,50,250,50,mg/kg,QD,5,,actoxumab-bezlotoxumab,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,10,2,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge+20 day recovery+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,,,,,,,,control,actoxumab-bezlotoxumab,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,15,8,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,p,27,UK1,100000,N/A,spores,10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,sustained,10,1,Clostridium difficile infection,positive,N/A,C57BL/6,N/A,49,6-8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",C. difficile spores,survival,F,t,27,UK1,100000,N/A,spores,10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,6,0,,positive,N/A,CD1,N/A,49,6-8 weeks,N/A,N/A,mouse,,25 ng each TcdA and TcdB + ip,C. difficile spores,survival,F,p,87,VPI 10463,5,ug,N/A,2.5 TcdA + 2.5 TcdB,0.1,0.1,0.1,mg/kg,QD,1,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,6,0,,positive,N/A,CD1,N/A,49,6-8 weeks,N/A,N/A,mouse,,25 ng each TcdA and TcdB + ip,C. difficile spores,survival,F,p,87,VPI 10463,5,ug,N/A,2.5 TcdA + 2.5 TcdB,1,1,1,mg/kg,QD,1,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,6,2,,positive,N/A,CD1,N/A,49,6-8 weeks,N/A,N/A,mouse,,25 ng each TcdA and TcdB + ip,C. difficile spores,survival,F,p,87,VPI 10463,5,ug,N/A,2.5 TcdA + 2.5 TcdB,10,10,10,mg/kg,QD,1,,actoxumab-bezlotoxumab,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25486992,25486992,25486992.txt,TRUE,2015,acute,6,0,,positive,N/A,CD1,N/A,49,6-8 weeks,N/A,N/A,mouse,,25 ng each TcdA and TcdB + ip,C. difficile spores,survival,F,p,87,VPI 10463,5,ug,N/A,2.5 TcdA + 2.5 TcdB,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,6,5,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,100,1000,50 vancomycin + 50 metronidazole,mg/kg,QD,10,50 mg/kg QD + 50 mg/kg QD for 10 days,vancomycin + metronidazole,infected control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,6,4,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,50,500,50,mg/kg,QD,10,,metronidazole,infected control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,6,6,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,50,500,50,mg/kg,QD,10,,vancomycin,infected control,equal,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,9,4,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,,,,,,,,infected control,Positive Control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,6,4,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,100,1000,50 vancomycin + 50 metronidazole,mg/kg,QD,10,50 mg/kg QD + 50 mg/kg QD for 10 days,vancomycin + metronidazole,infected control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,6,4,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,50,500,50,mg/kg,QD,10,,metronidazole,infected control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,6,3,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,50,500,50,mg/kg,QD,10,,vancomycin,infected control,equal,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,9,4,C. difficile infection (CDI),positive,N/A,C57BL/6J,F,49,6-8 weeks,19,18-19g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,200000,CFU,N/A,2x10^5,,,,,,,,infected control,Positive Control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,acute,10,5,Clostridium difficile infection,positive,N/A,C57/B6,F,49,6-8 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,8600000,CFU,N/A,8.6x10^6,20,140,20,mg/kg,QD,7,,metronidazole,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,acute,10,10,Clostridium difficile infection,positive,N/A,C57/B6,F,49,6-8 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,8600000,CFU,N/A,8.6x10^6,20,140,20,mg/kg,QD,7,,vancomycin,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,acute,10,3,Clostridium difficile infection,positive,N/A,C57/B6,F,49,6-8 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,8600000,CFU,N/A,8.6x10^6,,,,,,,,vehicle control,vancomycin 20mg/kg,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,sustained,10,5,Clostridium difficile infection,positive,N/A,C57/B6,F,49,6-8 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,8600000,CFU,N/A,8.6x10^6,20,140,20,mg/kg,QD,7,,metronidazole,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,sustained,10,3,Clostridium difficile infection,positive,N/A,C57/B6,F,49,6-8 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,8600000,CFU,N/A,8.6x10^6,20,140,20,mg/kg,QD,7,,vancomycin,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,sustained,10,3,Clostridium difficile infection,positive,N/A,C57/B6,F,49,6-8 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,8600000,CFU,N/A,8.6x10^6,,,,,,,,vehicle control,vancomycin 20mg/kg,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31921049,31921049,31921049.txt,TRUE,2019,acute,6,"7.3,7.5,7.5,7.6,7.7,7.8",Clostridioides difficile infection,positive,N/A,C57BL/6J,F,53,7-8 weeks,19,18-20g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,log10 CFU/gram,F,t,27,ATCC BAA-1870,10000000,CFU,N/A,10^7,400000000,3600000000,4x10^8,CFU,QD,9,,consortium of probiotics including five Lactobacilli strains and two Bifidobacterium strains,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31921049,31921049,31921049.txt,TRUE,2019,acute,12,"5.2,5.4,5.7,5.9,6.2,6.2,7.2,5.0,5.1,5.0,5.6,5.6",Clostridioides difficile infection,positive,N/A,C57BL/6J,F,53,7-8 weeks,19,18-20g,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,log10 CFU/gram,F,t,27,ATCC BAA-1870,10000000,CFU,N/A,10^7,,,,,,,,Negative Control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,acute,10,10,Clostridium difficile,positive,SPF,C57BL/6,N/A,56,7-9 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,1000000,CFU,vegetative,10^6,20,100,10,mg/kg,BID,5,,vancomycin,vehicle control,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,acute,10,10,Clostridium difficile,positive,SPF,C57BL/6,N/A,56,7-9 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,p,87,VPI 10463,1000000,CFU,vegetative,10^6,50,100,50,mg/kg,QD,2,,actoxumab-bezlotoxumab,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,acute,10,3,Clostridium difficile,positive,SPF,C57BL/6,N/A,56,7-9 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,1000000,CFU,vegetative,10^6,,,,,,,,vehicle control,vancomycin 20 mg/kg,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,sustained,10,2,Clostridium difficile,positive,SPF,C57BL/6,N/A,56,7-9 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,1000000,CFU,vegetative,10^6,20,100,10,mg/kg,BID,5,,vancomycin,vehicle control,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23542116,23542116,23542116.txt,TRUE,2013,,7,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,clindamycin+challenge,,cumulative mortality,T,p,,strain 117,,,,,,,,,,,,"mixture (MM) 
 constituted by kefir-isolated microorganisms (Lactobacillus plantarum, 
 Lactobacillus kefir, Lc. lactis, Kluyveromyces marxianus and Saccharomyces 
 cerevisiae)",Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/23542116,23542116,23542116.txt,TRUE,2013,,7,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,clindamycin+challenge,,cumulative mortality,T,p,,strain 117,,,,,,,,,,,,"mixture (MM) 
 constituted by kefir-isolated microorganisms (Lactobacillus plantarum, 
 Lactobacillus kefir, Lc. lactis, Kluyveromyces marxianus and Saccharomyces 
 cerevisiae)",CI,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/23611644,23611644,23611644.txt,TRUE,2013,,NA,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,clindamycin+challenge,,DD50/gram fecal sample,F,p,,strain 117,,,,,,,,,,,,Bifidobacterium,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,sustained,10,9,Clostridium difficile,positive,SPF,C57BL/6,N/A,56,7-9 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,p,87,VPI 10463,1000000,CFU,vegetative,10^6,50,100,50,mg/kg,QD,2,,actoxumab-bezlotoxumab,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,sustained,10,3,Clostridium difficile,positive,SPF,C57BL/6,N/A,56,7-9 weeks,N/A,N/A,mouse,,cefoperazone + clindamycin + challenge,,cumulative mortality,F,t,87,VPI 10463,1000000,CFU,vegetative,10^6,,,,,,,,vehicle control,vancomycin 20 mg/kg,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,8,4,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,"an inhibitor of pyruvate:ferredoxin 
 oxidoreductase (PFOR)","vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,Amixicile,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,8,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,Nitazoxanide,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,8,8,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,Vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,8,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,VPC161183,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,8,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,8,4,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,"an inhibitor of pyruvate:ferredoxin 
 oxidoreductase (PFOR)","vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,Amixicile,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,8,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,Nitazoxanide,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,8,1,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,Vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,8,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,20,100,20,mg/kg,QD,5,,VPC161183,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,8,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,10000,CFU,N/A,10^4,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,16,10,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,50000,N/A,N/A,10^4 to 10^5,20,100,20,mg/kg,QD,5,,nitazoxanide,Positive Control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,16,16,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,50000,N/A,N/A,10^4 to 10^5,20,100,20,mg/kg,QD,5,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,16,10,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,50000,N/A,N/A,10^4 to 10^5,20,100,20,mg/kg,QD,5,,nitazoxanide,Negative Control,equivalent,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,16,5,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,50000,N/A,N/A,10^4 to 10^5,20,100,20,mg/kg,QD,5,,vancomycin,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,10,7,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,"an inhibitor of pyruvate:ferredoxin 
 oxidoreductase (PFOR)","vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Amixicile,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,6,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Amixicile + Vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,10,8,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,10,8,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,acute,10,0,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,10,7,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,"an inhibitor of pyruvate:ferredoxin 
 oxidoreductase (PFOR)","vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Amixicile,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,6,1,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Amixicile + Vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,10,2,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,10,3,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,Vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22585229,22585229,22585229.txt,TRUE,2012,sustained,10,0,C. difficile disease,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,8,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,,,,,,,,control,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,8,8,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,50,50,mg/kg,QD,1,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,8,8,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,100,50,mg/kg,QD,2,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,8,8,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,150,50,mg/kg,QD,3,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,8,7,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,8,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,,,,,,,,control,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,8,4,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,50,50,mg/kg,QD,1,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,8,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,100,50,mg/kg,QD,2,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,8,1,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,150,50,mg/kg,QD,3,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,8,0,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,6,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,,,,,,,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,100,20,mg/kg,QD,5,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,200,20,mg/kg,QD,10,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,6,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,,,,,,,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,6,2,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,100,20,mg/kg,QD,5,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,6,0,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,200,20,mg/kg,QD,10,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,6,5,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,100,20,mg/kg,QD,5,,metronidazole,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,acute,6,6,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,100,20,mg/kg,QD,5,,Fidaxomicin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,6,5,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,100,20,mg/kg,QD,5,,metronidazole,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23147742,23147742,23147742.txt,TRUE,2012,sustained,6,1,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,N/A,N/A,10^5,20,100,20,mg/kg,QD,5,,Fidaxomicin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23217055,23217055,23217055.txt,TRUE,2012,acute,6,1,C. difficile,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,50,150,50,mg/kg,QD,3,,ATL370,Positive Control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23217055,23217055,23217055.txt,TRUE,2012,acute,6,6,C. difficile,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,50,150,50,mg/kg,QD,3,,vancomycin,Positive Control,equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23217055,23217055,23217055.txt,TRUE,2012,acute,6,6,C. difficile,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,50,150,50,mg/kg,QD,3,,vancomycin + ATL370,vancomycin,inferior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23217055,23217055,23217055.txt,TRUE,2012,sustained,6,1,C. difficile,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,50,150,50,mg/kg,QD,3,,ATL370,Negative Control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23217055,23217055,23217055.txt,TRUE,2012,sustained,6,0,C. difficile,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,50,150,50,mg/kg,QD,3,,vancomycin,Negative Control,superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23217055,23217055,23217055.txt,TRUE,2012,sustained,6,2,C. difficile,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,N/A,10^5,50,150,50,mg/kg,QD,3,,vancomycin + ATL370,vancomycin + ATL370,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26832756,26832756,26832756.txt,TRUE,2016,acute,19,19,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,vegetative,10^5,20,100,20,mg/kg,QD,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26832756,26832756,26832756.txt,TRUE,2016,acute,44,6,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,vegetative,10^5,,,,,,,,vehicle control,vancomycin 20 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26832756,26832756,26832756.txt,TRUE,2016,sustained,19,7,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,vegetative,10^5,20,100,20,mg/kg,QD,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26832756,26832756,26832756.txt,TRUE,2016,sustained,44,6,Clostridium difficile infection,positive,N/A,C57BL/6,M,56,8 weeks,N/A,N/A,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,100000,CFU,vegetative,10^5,,,,,,,,vehicle control,vancomycin 20 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,acute,5,3,Clostridium difficile infection,positive,N/A,C57BL/6,F,56,8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,1000000,CFU,vegetative,10^6,20,100,20,mg/kg,QD,5,,vancomycin,pbs control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,acute,7,0,Clostridium difficile infection,positive,N/A,C57BL/6,F,56,8 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,t,87,VPI 10463,1000000,CFU,vegetative,10^6,,,,,,,,pbs control,vancomycin 20mg/kg,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,acute,14,13,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,1.8,7.2,0.6,mg/kg,TID,4,,IT2S4,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,acute,17,17,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,36,144,12,mg/kg,TID,4,,IT2S4,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,acute,12,12,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,900,3600,300,mg/kg,TID,4,,IT2S4,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,acute,18,18,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,50,250,50,mg/kg,QD,5,,Vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,acute,14,14,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,18,72,6,mg/kg,TID,4,,IT2S4,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,acute,25,25,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,180,720,60,mg/kg,TID,4,,IT2S4,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,sustained,14,6,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,1.8,7.2,0.6,mg/kg,TID,4,,IT2S4,IT2S4,eqivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,sustained,17,7,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,36,144,12,mg/kg,TID,4,,IT2S4,vancomycin,eqivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,sustained,12,4,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,900,3600,300,mg/kg,TID,4,,IT2S4,vancomycin,eqivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,sustained,18,7,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,50,250,50,mg/kg,QD,5,,Vancomycin,IT2S4,eqivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,sustained,14,11,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,18,72,6,mg/kg,TID,4,,IT2S4,vancomycin,eqivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,sustained,25,9,C. difficile disease,positive,N/A,C57BL/6J,F,63,8-10 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,F,t,87,VPI 10463,500000,N/A,spores,5x10^5,180,720,60,mg/kg,TID,4,,IT2S4,vancomycin,eqivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,107,50,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.2,1,0.1,mg/kg,BID,5,,Cadazolid,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,11,1,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.2,1,0.1,mg/kg,BID,5,,vancomycin,Cadazolid,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,114,110,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,2,10,1,mg/kg,BID,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,17,15,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,2,10,1,mg/kg,BID,5,,vancomycin,Cadazolid,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,107,107,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,20,100,10,mg/kg,BID,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,11,11,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,20,100,10,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,137,24,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,cadazolid control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,acute,16,2,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,vancomycin control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,107,43,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.2,1,0.1,mg/kg,BID,5,,Cadazolid,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,11,1,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,0.2,1,0.1,mg/kg,BID,5,,vancomycin,Cadazolid,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,114,105,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,2,10,1,mg/kg,BID,5,,Cadazolid,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,17,12,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,2,10,1,mg/kg,BID,5,,vancomycin,Cadazolid,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,107,94,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,20,100,10,mg/kg,BID,5,,Cadazolid,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24890583,24890583,24890583.txt,TRUE,2014,,6,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,ileal loop + toxin A,,Histology score,T,p,,VPI 10463,,,,,,,,,,,,fidaxomicin,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24890583,24890583,24890583.txt,TRUE,2014,,6,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,ileal loop + toxin A,,Histology score,T,p,,VPI 10463,,,,,,,,,,,,fidaxomicin,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24890583,24890583,24890583.txt,TRUE,2014,,6,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,ileal loop + toxin A,,Histology score,F,p,,VPI 10463,,,,,,,,,,,,metronidazole,vancomycin,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24890583,24890583,24890583.txt,TRUE,2014,,6,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,ileal loop + toxin A,,Histology score,F,p,,VPI 10463,,,,,,,,,,,,metronidazole,Negative Control,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24890583,24890583,24890583.txt,TRUE,2014,,NA,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,ileal loop + toxin A,,Histology score,T,p,,VPI 10463,,,,,,,,,,,,OP-1118,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24890583,24890583,24890583.txt,TRUE,2014,,NA,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,ileal loop + toxin A,,Histology score,T,p,,VPI 10463,,,,,,,,,,,,OP-1118,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,11,9,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,20,100,10,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,137,17,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,cadazolid control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24277020,24277020,24277020.txt,TRUE,2014,sustained,16,2,C. difficile disease,positive,N/A,C57BL/6,F,70,8-12 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin, gentamicin, colistin, metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,t,87,VPI 10463,100000,CFU,spores,10^5,,,,,,,,vancomycin control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18848941,18848941,18848941.txt,TRUE,2008,acute,12,12,C. difficile disease,positive,N/A,C57BL/6,F,63,9 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,p,87,VPI 10463,10000,CFU,N/A,10^4,50,50,50,mg/kg,QD,1,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18848941,18848941,18848941.txt,TRUE,2008,acute,12,6,C. difficile disease,positive,N/A,C57BL/6,F,63,9 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,p,87,VPI 10463,10000,CFU,N/A,10^4,,,,,,,,control,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18848941,18848941,18848941.txt,TRUE,2008,sustained,12,5,C. difficile disease,positive,N/A,C57BL/6,F,63,9 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,p,87,VPI 10463,10000,CFU,N/A,10^4,50,50,50,mg/kg,QD,1,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18848941,18848941,18848941.txt,TRUE,2008,sustained,12,6,C. difficile disease,positive,N/A,C57BL/6,F,63,9 weeks,N/A,N/A,mouse,,"kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge","kanamycin,gentamicin,colistin,metronidazole,vancomycin+clindamycin+challenge",cumulative mortality,T,p,87,VPI 10463,10000,CFU,N/A,10^4,,,,,,,,control,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32351460,32351460,32351460.txt,TRUE,2020,acute,6,-0.1g,Clostridioides difficile,positive,N/A,C57BL/6,N/A,N/A,adult,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,body weight change,F,p,87,VPI 10463,100000,CFU,N/A,10^5,1000000000,4000000000,10^9,CFU,QD,4,,"Lactobacillus reuteri, LMG P-27481",Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32351460,32351460,32351460.txt,TRUE,2020,acute,6,0.2g,Clostridioides difficile,positive,N/A,C57BL/6,N/A,N/A,adult,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,body weight change,F,t,87,VPI 10463,100000,CFU,N/A,10^5,1000000000,4000000000,10^9,CFU,QD,4,,"Lactobacillus reuteri, LMG P-27481",Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32351460,32351460,32351460.txt,TRUE,2020,acute,6,-1.5g,Clostridioides difficile,positive,N/A,C57BL/6,N/A,N/A,adult,N/A,N/A,mouse,,cefoperazone+challenge,cefoperazone+challenge,body weight change,F,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,Negative Control,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,acute,9,8,Clostridioides difficile,positive,N/A,Golden Syrian,F,N/A,adult,95,80-110g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,27,CD13-12,5000,CFU,spores,5x10^3,1000000,1000000,10^6,spores,QD,1,,PCD130 + 027,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,acute,9,8,Clostridioides difficile,positive,N/A,Golden Syrian,F,N/A,adult,95,80-110g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,27,CD13-12,5000,CFU,spores,5x10^3,1000000,1000000,10^6,spores,QD,1,,PCD182 + 027,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,acute,8,0,Clostridioides difficile,positive,N/A,Golden Syrian,F,N/A,adult,95,80-110g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,27,CD13-12,5000,CFU,spores,5x10^3,,,,,,,,negative control,PCD130 + 027,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,sustained,9,5,Clostridioides difficile,positive,N/A,Golden Syrian,F,N/A,adult,95,80-110g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,27,CD13-12,5000,CFU,spores,5x10^3,1000000,1000000,10^6,spores,QD,1,,PCD130 + 027,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,sustained,9,8,Clostridioides difficile,positive,N/A,Golden Syrian,F,N/A,adult,95,80-110g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,27,CD13-12,5000,CFU,spores,5x10^3,1000000,1000000,10^6,spores,QD,1,,PCD182 + 027,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,sustained,8,0,Clostridioides difficile,positive,N/A,Golden Syrian,F,N/A,adult,95,80-110g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,27,CD13-12,5000,CFU,spores,5x10^3,,,,,,,,negative control,PCD130 + 027,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CamSA,CapSA,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CamSA,CaoSA,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CamSA,vancomycin,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CapSA,CamSA,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CapSA,CaoSA,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CapSA,vancomycin,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CaoSA,CapSA,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CaoSA,CamSA,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,CaoSA,vancomycin,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,vancomycin,CapSA,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,vancomycin,CamSA,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30012758,30012758,30012758.txt,TRUE,2018,,5,,C. difficile disease,positive,,Golden Syrian,F,,,,,hamster,,challenge+clindamycin,,cumulative mortality,F,t,,630,,,,,,,,,,,,vancomycin,CaoSA,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,,NA,,C. difficile disease,positive,,Germ Free,F,,,,,mouse,,ecoli JM83 + fecal slur,,extent of cleavage,F,t,,NAP1,,,,,,,,,,,,IP2S4,inositol hexakisphosphate (IP6),equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30482680,30482680,30482680.txt,TRUE,2018,,NA,,C. difficile disease,positive,,Germ Free,F,,,,,mouse,,ecoli JM83 + fecal slur,,extent of cleavage,F,t,,NAP1,,,,,,,,,,,,inositol hexakisphosphate (IP6),IP2S4,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/8429534,8429534,8429534.txt,TRUE,1993,acute,13,13,C. difficile,positive,N/A,Golden Syrian,N/A,N/A,adult,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,development of enterocaecitis,T,p,,B-1,10000,CFU,N/A,log10 4.0,,,,,,,,caecal contents,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/8429534,8429534,8429534.txt,TRUE,1993,acute,26,2,C. difficile,positive,N/A,Golden Syrian,N/A,N/A,adult,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,development of enterocaecitis,T,p,,B-1,10000,CFU,N/A,log10 4.0,,,,,,,,Negative Control,caecal contents,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,33,32,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,20,100,10,mg/kg,BID,5,,"CB-183,315",Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,24,24,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,20,100,10,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,32,32,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,4,20,2,mg/kg,BID,5,,"CB-183,315",Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,24,24,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,4,20,2,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,16,16,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,50,250,25,mg/kg,BID,5,,"CB-183,315",Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,16,16,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,50,250,25,mg/kg,BID,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,acute,15,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,33,25,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,20,100,10,mg/kg,BID,5,,"CB-183,315",vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,24,21,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,20,100,10,mg/kg,BID,5,,vancomycin,"CB-183,315",superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,32,16,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,4,20,2,mg/kg,BID,5,,"CB-183,315",vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,24,13,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,4,20,2,mg/kg,BID,5,,vancomycin,"CB-183,315",superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,16,13,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,50,250,25,mg/kg,BID,5,,"CB-183,315",vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,16,11,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,50,250,25,mg/kg,BID,5,,vancomycin,"CB-183,315",superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22802252,22802252,22802252.txt,TRUE,2012,sustained,15,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,ATCC 43596,20,N/A,spores,20,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,acute,8,8,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,ATCC 43596,20,N/A,spores,20,0.5,2.5,0.5,mg/kg,QD,5,,surotomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,acute,8,8,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,ATCC 43596,20,N/A,spores,20,0.5,2.5,0.5,mg/kg,QD,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,acute,5,0,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,ATCC 43596,20,N/A,spores,20,,,,,,,,vehicle control,vancomycin 0.5 mg/kg,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,sustained,8,8,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,ATCC 43596,20,N/A,spores,20,0.5,2.5,0.5,mg/kg,QD,5,,surotomycin,vancomycin 0.5 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30988143,30988143,30988143.txt,TRUE,2019,,40,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,cefoperazone+challenge,,cumulative mortality,F,p,,VPI 10463,,,,,,,,,,,,Lactobacillus and Bifidobacterium probiotics,Positive Control,superior,superior,graphs in suplimental file,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30988143,30988143,30988143.txt,TRUE,2019,,40,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,cefoperazone+challenge,,cumulative mortality,F,p,,VPI 10463,,,,,,,,,,,,Lactobacillus and Bifidobacterium probiotics,probiotics,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30988143,30988143,30988143.txt,TRUE,2019,,40,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,cefoperazone+challenge,,cumulative mortality,F,p,,VPI 10463,,,,,,,,,,,,Lactobacillus and Bifidobacterium probiotics,Vancomycin,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/19523775,19523775,19523775.txt,TRUE,2009,,NA,,Clostridium difficile,positive,,NA,NA,,,,,dog,,challenge ,,Adhesion to epithelial cells,T,t,,NA,,,,,,,,,,,,Bifidobacterium animalis AHC7,Lactobacillus,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,sustained,8,2,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,ATCC 43596,20,N/A,spores,20,0.5,2.5,0.5,mg/kg,QD,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,sustained,5,0,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,ATCC 43596,20,N/A,spores,20,,,,,,,,vehicle control,vancomycin 0.5 mg/kg,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22431852,22431852,22431852.txt,TRUE,2012,,NA,,Clostridium difficile infection,positive,,NA,NA,,,,,hamster,,C. diff spores,,quantity of colony-forming units,T,t,,ATCC 13709,,,,,,,,,,,,oritavancin,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22431852,22431852,22431852.txt,TRUE,2012,,NA,,Clostridium difficile infection,positive,,NA,NA,,,,,hamster,,C. diff spores,,quantity of colony-forming units,T,t,,ATCC 13709,,,,,,,,,,,,vancomycin,oritavancin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,22,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,oritavancin,Positive Control,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,22,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,oritavancin,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,22,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,oritavancin,clindamycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,22,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,vancomycin,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,22,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,vancomycin,oritavancin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,22,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,vancomycin,clindamycin,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,10,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,clindamycin,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,10,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,clindamycin,oritavancin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22899803,22899803,22899803.txt,TRUE,2012,,10,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,C. diff spores,,cumulative mortality,F,p,,NA,,,,,,,,,,,,clindamycin,vancomycin,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,acute,5,4,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,3.12,12.48,1.56,mg/kg,BID,4,,Kibdelomycin,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,25,100,12.5,mg/kg,BID,4,,Kibdelomycin,vehicle control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23133377,23133377,23133377.txt,TRUE,2012,,NA,,Relapsing C. difficile,positive,SPF,multiple,F,,,,,mouse,,challenge+clindamycin,,microbiome diversity,F,t,,027/BI-7,,,,,,,,,,,,vancomycin,feces from healthy mouse,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/23133377,23133377,23133377.txt,TRUE,2012,,NA,,Relapsing C. difficile,positive,SPF,multiple,F,,,,,mouse,,challenge+clindamycin,,microbiome diversity,F,t,,027/BI-7,,,,,,,,,,,,feces from healthy mouse,vancomycin,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,12.5,50,6.25,mg/kg,BID,4,,Kibdelomycin,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,12.5,50,6.25,mg/kg,BID,4,,vancomycin,vehicle control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,sustained,5,4,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,3.12,12.48,1.56,mg/kg,BID,4,,Kibdelomycin,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,sustained,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,25,100,12.5,mg/kg,BID,4,,Kibdelomycin,untreated control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,sustained,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,12.5,50,6.25,mg/kg,BID,4,,Kibdelomycin,vancomycin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/24514098,24514098,24514098.txt,TRUE,2014,sustained,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,98,98g,hamster,inhibitor of type II topoisomerase enzymes,clindamycin+challenge,,cumulative mortality,T,t,53,B1,53,N/A,spores,53,12.5,50,6.25,mg/kg,BID,4,,vancomycin,untreated control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,50,12,C. difficile disease,positive,N/A,Swiss Webster,N/A,N/A,N/A,N/A,N/A,mouse,antibody,toxin A intraperitoneally,,survival,F,p,87,VPI 10463,100,ng Toxin A,N/A,100,,,100 to 250,ug,,,,1B11,Negative Control,equivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,70,52,C. difficile disease,positive,N/A,Swiss Webster,N/A,N/A,N/A,N/A,N/A,mouse,antibody,toxin A intraperitoneally,,survival,F,p,87,VPI 10463,100,ng Toxin A,N/A,100,,,100 to 250,ug,,,100 to 250 ug,3H2,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,90,60,C. difficile disease,positive,N/A,Swiss Webster,N/A,N/A,N/A,N/A,N/A,mouse,antibody,toxin A intraperitoneally,,survival,F,p,87,VPI 10463,100,ng Toxin A,N/A,100,,,100 to 250,ug,,,100 to 250 ug,CDA1,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,105,24,C. difficile disease,positive,N/A,Swiss Webster,N/A,N/A,N/A,N/A,N/A,mouse,antibody,toxin A intraperitoneally,,survival,F,p,87,VPI 10463,100,ng Toxin A,N/A,100,,,,,,,,control - irrelevant humab,Negative Control,equivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/23359592,23359592,23359592.txt,TRUE,2013,,NA,,C. difficile,positive,,C57BL/6,M,,,,,mouse,,Toxin B,,cumulative mortality,T,p,,"VPI 
 
 10463",,,,,,,,,,,,Alanyl-glutamine,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,17,3,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,,,10 to 50,mg/kg,QD,4,10 to 50 mg/kg for 4 days,MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,42,23,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,50,200,50,mg/kg,QD,4,,CDA1,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,65,61,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,,,50 CDA1 + 10 to 50 MDX1388,mg/kg,QD,4,50 mg/kg QD CDA1 + 10 to 50 mg/kg QD MDX1388 for 4 days,CDA1 + MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,55,3,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,17,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,,,10 to 50,mg/kg,QD,4,10 to 50 mg/kg for 4 days,MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,42,2,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,50,200,50,mg/kg,QD,4,,CDA1,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,65,36,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,,,50 CDA1 + 10 to 50 MDX1388,mg/kg,QD,4,,CDA1 + MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,55,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge,,cumulative mortality,F,p,87,VPI 10463,140,CFU,spores,140,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,acute,10,10,Clostridium difficile,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,630,680,CFU,spores,680,20,100,10,mg/kg,BID,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,acute,10,5,Clostridium difficile,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,p,12,630,680,CFU,spores,680,50,200,50,mg/kg,QD,4,,actoxumab-bezlotoxumab,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,acute,10,0,Clostridium difficile,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,630,680,CFU,spores,680,,,,,,,,vehicle control,vancomycin 20 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,sustained,10,0,Clostridium difficile,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,630,680,CFU,spores,680,20,100,10,mg/kg,BID,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,sustained,10,4,Clostridium difficile,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,p,12,630,680,CFU,spores,680,50,200,50,mg/kg,QD,4,,actoxumab-bezlotoxumab,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27527088,27527088,27527088.txt,TRUE,2016,sustained,10,0,Clostridium difficile,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,F,t,12,630,680,CFU,spores,680,,,,,,,,vehicle control,vancomycin 20 mg/kg,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,15,4,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,20,80,20,mg/kg,QD,4,,MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,22,15,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,80,320,60 CDA1 + 20 MDX1388,mg/kg,QD,4,60 mg/kg QD CDA1 + 20 mg/kg QD MDX1388 for 4 days,CDA1 + MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,86,48,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,60,240,60,mg/kg,QD,4,,CDA1,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,acute,82,31,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,15,4,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,20,80,20,mg/kg,QD,4,,MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,22,15,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,80,320,60 CDA1 + 20 MDX1388,mg/kg,QD,4,60 mg/kg QD CDA1 + 20 mg/kg QD MDX1388 for 4 days,CDA1 + MDX1388,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,86,28,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,60,240,60,mg/kg,QD,4,,CDA1,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/16966409,16966409,16966409.txt,TRUE,2006,sustained,82,18,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,75,70-80g,hamster,,clindamycin+challenge+vancomycin,,cumulative mortality,F,t,87,VPI 10463,140000,CFU,spores,140000,,,,,,,,control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,2,10,1,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,3,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,2,10,1,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,20,100,10,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,20,100,10,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,20,100,10,mg/kg,BID,5,,vancomycin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,20,100,10,mg/kg,BID,5,,vancomycin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,25,125,12.5,mg/kg,BID,5,,SMT19969,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,25,125,12.5,mg/kg,BID,5,,SMT19969,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,5,25,2.5,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,4,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,5,25,2.5,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,50,250,25,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,50,250,25,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,50,250,25,mg/kg,BID,5,,SMT19969,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,8,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,50,250,25,mg/kg,BID,5,,SMT19969,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,,,,,,,,vehicle control,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,225,N/A,spores,~100-350,,,,,,,,vehicle control,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,2,10,1,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,9,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,2,10,1,mg/kg,BID,5,,fidaxomicin,SMT19969 12.5 mg/kg BID,eqivalent,eqivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,20,100,10,mg/kg,BID,5,,vancomycin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,1,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,20,100,10,mg/kg,BID,5,,vancomycin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,25,125,12.5,mg/kg,BID,5,,SMT19969,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,9,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,25,125,12.5,mg/kg,BID,5,,SMT19969,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,5,25,2.5,mg/kg,BID,5,,fidaxomicin,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,9,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,5,25,2.5,mg/kg,BID,5,,fidaxomicin,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,50,250,25,mg/kg,BID,5,,SMT19969,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,10,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,50,250,25,mg/kg,BID,5,,SMT19969,vehicle control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,acute,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,,,,,,,,vehicle control,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25652749,25652749,25652749.txt,TRUE,2015,sustained,10,0,Clostridium difficile infection,positive,SPF,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,BI1,225,N/A,spores,~100-350,,,,,,,,vehicle control,SMT19969 25 mg/kg BID,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,11,1,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,,,,,,,,control,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,sustained,11,0,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,,,,,,,,control,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,300,50,mg/kg,BID,3,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,sustained,6,1,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,300,50,mg/kg,BID,3,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,300,50,mg/kg,BID,3,,MorE-DCBG (362E),control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,sustained,6,1,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,300,50,mg/kg,BID,3,,MorE-DCBG (362E),control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,sustained,5,3,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,700,50,mg/kg,BID,7,,MorE-DCBG (362E),vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,Berberine,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,Berberine,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,Berberine,vancomycin,equivalent,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,Berberine,vancomycin + berberine,equivalent,eqivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,700,50,mg/kg,BID,7,,MorE-DCBG (362E),vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,Berberine,equivalent,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,vancomycin + berberine,equivalent,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin + berberine,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin + berberine,Negative Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin + berberine,vancomycin,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25824219,25824219,25824219.txt,TRUE,2015,,10,,"Clostridium difficile 
 
 infection",positive,SPF,C57BL/6,M,,5-6 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin + berberine,Berberine,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,sustained,5,5,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,1400,50,mg/kg,BID,14,,MorE-DCBG (362E),vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,5000000,CFU,spores,0.5x10^7,100,1400,50,mg/kg,BID,14,,MorE-DCBG (362E),vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,acute,8,8,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,0.5 mg/kg QD,surotomycin ,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,acute,8,8,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,0.5 mg/kg QD,vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,30,93.75,10,ml/kg,TID,3.125,,anti-CD-WPI induces a TcdA neutralization capacity of 100,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,30,93.75,10,ml/kg,TID,3.125,,anti-CD-WPI induces a TcdA neutralization capacity of 1000,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,30,93.75,10,ml/kg,TID,3.125,,anti-CD-WPI induces a TcdA neutralization capacity of 10000,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,20,60,20,mg/kg,QD,3,,Vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,sustained,10,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,30,93.75,10,ml/kg,TID,3.125,,anti-CD-WPI induces a TcdA neutralization capacity of 100,Vancomycin,eqivalent,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,sustained,8,8,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,0.5 mg/kg QD,surotomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,sustained,10,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,30,93.75,10,ml/kg,TID,3.125,,anti-CD-WPI induces a TcdA neutralization capacity of 1000,Vancomycin,eqivalent,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25993059,25993059,25993059.txt,TRUE,2015,sustained,8,2,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,0.5 mg/kg QD,vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,sustained,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,30,93.75,10,ml/kg,TID,3.125,,anti-CD-WPI induces a TcdA neutralization capacity of 10000,Vancomycin,eqivalent,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30736358,30736358,30736358.txt,TRUE,2019,sustained,10,1,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,"89.5114 g, mean 100.4 g",hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,12,630,100,N/A,spores,10^2,20,60,20,mg/kg,QD,3,,Vancomycin,"anti-C. difficile 
 whey protein isolates (anti-CD-WPI)",equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/7309245,7309245,7309245.txt,TRUE,1981,acute,30,24,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,85,70-100g,hamster,,vancomyin + challenge,clindamycin + challenge,survivors,F,p,,49A,100000,CFU,N/A,10^5,,,,,,,,cecal homogenates,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/7309245,7309245,7309245.txt,TRUE,1981,acute,20,1,Clostridium difficile,positive,N/A,Golden Syrian,M,N/A,N/A,85,70-100g,hamster,,vancomyin + challenge,clindamycin + challenge,survivors,F,p,,49A,100000,CFU,N/A,10^5,,,,,,,,negative control,cecal homogenates,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26286574,26286574,26286574.txt,TRUE,2015,,>=8,,"Clostridium difficile 
 
 infection",positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,,metronidazole,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/26286574,26286574,26286574.txt,TRUE,2015,,>=8,,"Clostridium difficile 
 
 infection",positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,,metronidazole,series of metronidazole-bearing tetramic acid substituents,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/26286574,26286574,26286574.txt,TRUE,2015,,>=8,,"Clostridium difficile 
 
 infection",positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,,series of metronidazole-bearing tetramic acid substituents,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/26286574,26286574,26286574.txt,TRUE,2015,,>=8,,"Clostridium difficile 
 
 infection",positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,F,t,,ATCC 43596,,,,,,,,,,,,series of metronidazole-bearing tetramic acid substituents,metronidazole,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,150,900,150,mg/kg,QD,6,,metronidazole,vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26461425,26461425,26461425.txt,TRUE,2015,,10,,Clostridium difficile,positive,,C57BL/6,F,,5-6 weeks,,,mouse,,"ampicillin,kanamycin,gentamycin,colistin,metronidazole,vancomycin+clindamycin+challenge",,cumulative mortality,F,p,,UK6 (027/BI21/NAP1),,,,,,,,,,,,Clostridium difficile CD37,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,150,900,150,mg/kg,QD,6,,nitazoxanide,metronidazole,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,6,5,C. difficile infection (CDI),positive,,C57BL/6J,F,,6-8 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin 50 mg/kg + metronidazole 50 mg/kg,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,acute,10,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,30,180,30,mg/kg,QD,6,,nitazoxanide,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,6,6,C. difficile infection (CDI),positive,,C57BL/6J,F,,6-8 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin 50 mg/kg,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,50,300,50,mg/kg,QD,6,,vancomycin,metronidazole,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,acute,6,4,C. difficile infection (CDI),positive,,C57BL/6J,F,,6-8 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,metronidazole 50mg/kg,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,75,450,75,mg/kg,QD,6,,nitazoxanide,metronidazole,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,acute,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,,,,,,,,saline control,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,6,4,C. difficile infection (CDI),positive,,C57BL/6J,F,,6-8 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin 50 mg/kg + metronidazole 50 mg/kg,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,150,900,150,mg/kg,QD,6,,metronidazole,vancomycin,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,150,900,150,mg/kg,QD,6,,nitazoxanide,metronidazole,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,6,3,C. difficile infection (CDI),positive,,C57BL/6J,F,,6-8 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin 50 mg/kg,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,30,180,30,mg/kg,QD,6,,nitazoxanide,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26568840,26568840,26568840.txt,TRUE,2015,sustained,6,4,C. difficile infection (CDI),positive,,C57BL/6J,F,,6-8 weeks,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,metronidazole 50mg/kg,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,sustained,10,3,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,50,300,50,mg/kg,QD,6,,vancomycin,metronidazole,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,75,450,75,mg/kg,QD,6,,nitazoxanide,metronidazole,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/10952564,10952564,10952564.txt,TRUE,2000,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,,TTU 614,100000,N/A,N/A,10^5,,,,,,,,saline control,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/15388461,15388461,15388461.txt,TRUE,2004,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,113,100-125g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,rifalazil,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/15388461,15388461,15388461.txt,TRUE,2004,acute,14,14,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,113,100-125g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/26832756,26832756,26832756.txt,TRUE,2016,,13,,Clostridium difficile infection,positive,,C57BL/6,M,,8 weeks,,,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,SQ641,vehicle control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/26832756,26832756,26832756.txt,TRUE,2016,,13,,Clostridium difficile infection,positive,,C57BL/6,M,,8 weeks,,,mouse,,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,SQ641,vancomycin 20 mg/kg,inferior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/15388461,15388461,15388461.txt,TRUE,2004,acute,10,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,113,100-125g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,vehicle control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/15388461,15388461,15388461.txt,TRUE,2004,sustained,10,10,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,113,100-125g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,20,100,20,mg/kg,QD,5,,rifalazil,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/15388461,15388461,15388461.txt,TRUE,2004,sustained,14,5,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,113,100-125g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/15388461,15388461,15388461.txt,TRUE,2004,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,113,100-125g,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,vehicle control,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27262694,27262694,27262694.txt,TRUE,2016,,6,,Clostridium difficile.,positive,,NA,NA,,,,,dogs,,challenge + antibiotics,,gut microflora depopulation,T,t,,NA,,,,,,,,,,,,SYN-004,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/27262694,27262694,27262694.txt,TRUE,2016,,7,,Clostridium difficile.,positive,,NA,NA,,,,,pigs,,challenge + antibiotics,,gut microflora depopulation,T,t,,NA,,,,,,,,,,,,SYN-004,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,10,8,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,p,87,VPI 10463,100000,CFU,N/A,10^5,100,500,100,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,20,18,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,100,500,100,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,10,6,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,p,87,VPI 10463,100000,CFU,N/A,10^5,25,125,25,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,20,9,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,25,125,25,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,10,7,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,p,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,20,13,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,10,7,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,p,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,Vancomycin,rifaximin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,20,18,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,Vancomycin,rifaximin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,10,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,p,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,vehicle control,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,acute,20,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,vehicle control,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,100,500,100,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,sustained,1,1,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,25,125,25,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,sustained,3,3,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,rifaximin,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,sustained,8,2,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,50,250,50,mg/kg,QD,5,,Vancomycin,rifaximin,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/18195066,18195066,18195066.txt,TRUE,2008,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,100000,CFU,N/A,10^5,,,,,,,,vehicle control,Negative Control,inferior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,Tiacumicins B,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,Tiacumicins C,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/27573235,27573235,27573235.txt,TRUE,2016,,57,,Clostridium difficile-associated diarrhea,positive,,ICR,M,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,NA,,,,,,,,,,,,Lactobacillus rhamnosus L34,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/27707993,27707993,27707993.txt,TRUE,2017,,9,,Clostridium difficile,positive,,NA,NA,,,,,mouse,,none (test was for vancomycin side effects),,microbiome diversity,F,t,,NA,,,,,,,,,,,,vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/27707993,27707993,27707993.txt,TRUE,2017,,9,,Clostridium difficile,positive,,NA,NA,,,,,human,,none (test was for vancomycin side effects),,microbiome diversity,F,t,,NA,,,,,,,,,,,,vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28453386,28453386,28453386.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,NA ,NA ,,,,,mouse,,challenge,,cumulative mortality,F,t,,NA,,,,,,,,,,,,Vancomycin  young mouse,Vancomycin  old mouse,equivalent,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28739791,28739791,28739791.txt,TRUE,2017,,215,,Clostridium difficile infection.,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,C. difficile 027,,,,,,,,,,,,DAV131A,Positive Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28747822,28747822,28747822.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,PCR ribotype 027,,,,,,,,,,,,Bifidobacterium longum ATCC 15707 live cell,Antibiotics,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28747822,28747822,28747822.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,PCR ribotype 027,,,,,,,,,,,,Bifidobacterium longum ATCC 15707 live cell,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28747822,28747822,28747822.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,PCR ribotype 027,,,,,,,,,,,,Bifidobacterium longum ATCC 15707 live cell,Bifidobacterium longum ATCC 15707 dead cell,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28747822,28747822,28747822.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,PCR ribotype 027,,,,,,,,,,,,Bifidobacterium longum ATCC 15707 dead cell,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28747822,28747822,28747822.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,PCR ribotype 027,,,,,,,,,,,,Bifidobacterium longum ATCC 15707 dead cell,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28747822,28747822,28747822.txt,TRUE,2017,,NA,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,PCR ribotype 027,,,,,,,,,,,,Bifidobacterium longum ATCC 15707 dead cell,Bifidobacterium longum ATCC 15707 live cell,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/28801119,28801119,28801119.txt,TRUE,2017,,22,,C. difficile infection,positive,,C57BL/6J,M,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,fecal microbiota transplantation,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,trifluoperazine,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,trifluoperazine,amoxapine,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,trifluoperazine,doxapram,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,trifluoperazine,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,amoxapine,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,amoxapine,trifluoperazine,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,amoxapine,doxapram,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,amoxapine,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,doxapram,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,doxapram,trifluoperazine,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,doxapram,amoxapine,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,doxapram,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,5,3,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,Tiacumicins B,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,trifluoperazine,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,amoxapine,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29109161,29109161,29109161.txt,TRUE,2017,,7,,Clostridium difficile infection,positive,,C57BL/6,F,,,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,doxapram,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29360463,29360463,29360463.txt,TRUE,2018,,NA,,Clostridium difficile,positive,,C57BL/6J,M/F,,,,,mouse,,clindamycin + challenge,,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,CSA13-Eudragit,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,Tiacumicins B,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,,6,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,2009155 (NAP1/027),,,,,,,,,,,,DS-2969b,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,,6,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,2009155 (NAP1/027),,,,,,,,,,,,DS-2969b,fidaxomicin 3 mg/kg,eqivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,,6,,Clostridium difficile infection,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,2009155 (NAP1/027),,,,,,,,,,,,DS-2969b,vancomycin 100 mg/kg,eqivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,Tiacumicins C,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,5,3,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,vancomycin,Tiacumicins B,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,vancomycin,Tiacumicins B,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,Tiacumicins B,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,Tiacumicins B,Tiacumicins C,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,Tiacumicins C,Tiacumicins B,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,vancomycin,Tiacumicins B,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,vancomycin,Tiacumicins C,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,5,3,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,,,,,,,,control,control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,acute,8,6,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,,,,,,,,control,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,Tiacumicins B,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,Tiacumicins C,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,0.2,1,0.2,mg/kg,QD,5,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,5,3,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,Tiacumicins B,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,Tiacumicins B,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,Tiacumicins C,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29463537,29463537,29463537.txt,TRUE,2018,,NA,,Clostridium difficile infection,positive,SPF,C57BL/6,F,,6-8 weeks,,,mouse,,challenge,,alpha diversity,F,t,,VPI 10463,,,,,,,,,,,,fidaxomicin,Negative Control,superior,NA,questionable - strange induction,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29463537,29463537,29463537.txt,TRUE,2018,,NA,,Clostridium difficile infection,positive,SPF,C57BL/6,F,,6-8 weeks,,,mouse,,challenge,,alpha diversity,F,t,,VPI 10463,,,,,,,,,,,,fidaxomicin,vancomycin,eqivalent,NA,questionable - strange induction,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29463537,29463537,29463537.txt,TRUE,2018,,NA,,Clostridium difficile infection,positive,SPF,C57BL/6,F,,6-8 weeks,,,mouse,,challenge,,alpha diversity,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,Negative Control,superior,NA,questionable - strange induction,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29463537,29463537,29463537.txt,TRUE,2018,,NA,,Clostridium difficile infection,positive,SPF,C57BL/6,F,,6-8 weeks,,,mouse,,challenge,,alpha diversity,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,fidaxomicin,eqivalent,NA,questionable - strange induction,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,,Clostridium difficile infection,positive,,C57BL/6,F,,10 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,% initial body weight,F,t,,VPI 10463,,,,,,,,,,,,small-molecule inhibitor (VB-82252),Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,,Clostridium difficile infection,positive,,C57BL/6,F,,10 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,% initial body weight,F,t,,VPI 10463,,,,,,,,,,,,small-molecule inhibitor (VB-82252),Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,,Clostridium difficile infection,positive,,C57BL/6,F,,10 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,% initial body weight,F,t,,VPI 10463,,,,,,,,,,,,small-molecule inhibitor (VB-82252),vancomycin,inferior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,,Clostridium difficile infection,positive,,C57BL/6,F,,10 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,% initial body weight,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,Positive Control,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,5,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,vancomycin,Tiacumicins B,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,1,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,1,5,1,mg/kg,QD,5,,vancomycin,Tiacumicins B,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29483125,29483125,29483125.txt,TRUE,2018,acute,8,,Clostridium difficile infection,positive,,C57BL/6,F,,10 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,% initial body weight,F,t,,VPI 10463,,,,,,,,,,,,vancomycin,small-molecule inhibitor (VB-82252),superior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,Tiacumicins B,vancomycin,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,Tiacumicins B,Tiacumicins C,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,Tiacumicins C,Tiacumicins B,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,5,5,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,vancomycin,Tiacumicins B,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,vancomycin daily for 10 days,Negative Control,superior,superior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,vancomycin daily for 10 days,vancomycin in a tapering dose for 42 days,inferior,inferior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,vancomycin daily for 10 days,fidaxomicin,superior,superior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,vancomycin in a tapering dose for 42 days,Negative Control,superior,superior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,vancomycin in a tapering dose for 42 days,vancomycin daily for 10 days,superior,superior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,vancomycin in a tapering dose for 42 days,fidaxomicin,superior,superior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,fidaxomicin,Negative Control,inferior,inferior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,fidaxomicin,vancomycin daily for 10 days,inferior,inferior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29530853,29530853,29530853.txt,TRUE,2018,,5,,Clostridium difficile infections,positive,,CF-1 outbred white,F,,,,,mouse,,challenge,,log10 CFU/gram,F,t,,VA17,,,,,,,,,,,,fidaxomicin,vancomycin in a tapering dose for 42 days,inferior,inferior,difficult to assess outcome data,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,3,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,5,25,5,mg/kg,QD,5,,vancomycin,Tiacumicins C,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,5,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,,2926,1000000,N/A,N/A,10^6,,,,,,,,control,control,inferior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/1929250,1929250,1929250.txt,TRUE,1991,sustained,8,2,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,oral,cumulative mortality,T,t,1,ATCC9689,1000000,N/A,N/A,10^6,,,,,,,,control,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,10,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,p,,HUC 2-4,1000000,CFU,N/A,10^6,1000,7000,1000,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,7,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,1000,7000,1000,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,7,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,1500,10500,1500,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,10,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,210,1050,210,mg/kg,QD,5,,metronidazole,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,8,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,p,,HUC 2-4,1000000,CFU,N/A,10^6,500,3500,500,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. gasseri APC 678,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. gasseri APC 678,L. rhamnosus DPC 6111,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. gasseri APC 678,L. gasseri ATCC 33323,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. rhamnosus DPC 6111,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. rhamnosus DPC 6111,L. gasseri APC 678,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. rhamnosus DPC 6111,L. gasseri ATCC 33323,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. gasseri ATCC 33323,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. gasseri ATCC 33323,L. gasseri APC 678,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/30842760,30842760,30842760.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,C57BL/6,F,,,,,mouse,,challenge,,Log CFU per m-1,F,t,,VPI 10463,,,,,,,,,,,,L. gasseri ATCC 33323,L. rhamnosus DPC 6111,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31178844,31178844,31178844.txt,TRUE,2019,,NA,,Clostridium difficile,positive,,NA,NA,,,,,mouse,,challenge,,spore germination inhibition,F,t,,NA,,,,,,,,,,,,vancomycin-loaded spore-targeting iron oxide nanoparticle (van-IONP),Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31406331,31406331,31406331.txt,FALSE,2019,,10,,C. difficile disease,positive,,C57BL/6,M,,,,,mouse,,challenge,,C diff spores found,F,t,,C. difficile M7404,,,,,,,,,,,,"the current standard-of-care antibiotic, vancomycin, and a cephamycin",Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31560732,31560732,31560732.txt,TRUE,2019,,11,,Clostridium difficile (Cd) infection,positive,,Wild Type,M,,,,,mouse,,challenge,,cumulative mortality,F,p,,Cd630 or CdVPI,,,,,,,,,,,,fecal microbiota transplantation,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31636067,31636067,31636067.txt,TRUE,2019,,10-Sep,,Clostridioides difficile,positive,,Golden Syrian,M,,,,,hamsters,,challenge,,cumulative mortality,T,t,,UNT103-1,,,,,,,,,,,,levofloxacin + DAV131A,ciprofloxacin + DAV131A,eqivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31636067,31636067,31636067.txt,TRUE,2019,,10-Sep,,Clostridioides difficile,positive,,Golden Syrian,M,,,,,hamsters,,challenge,,cumulative mortality,T,t,,UNT103-1,,,,,,,,,,,,ciprofloxacin + DAV131A,levofloxacin + DAV131A,eqivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31748246,31748246,31748246.txt,TRUE,2019,,3-Feb,,Clostridioides difficile infections,positive,,C57BL/6,M/F,,,,,mouse,,clindamycin + challenge,,structure of the gut microbiota,F,t,,C. difficile strain 630,,,,,,,,,,,,omeprazole,Negative Control,eqivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,,10,,Clostridium difficile infection,positive,,C57/B6,F,,6-8 weeks,,,mouse,,cefoperazone + challenge,,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,TNP-2092,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,,10,,Clostridium difficile infection,positive,,C57/B6,F,,6-8 weeks,,,mouse,,cefoperazone + challenge,,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,TNP-2092,metronidazole,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,,10,,Clostridium difficile infection,positive,,C57/B6,F,,6-8 weeks,,,mouse,,cefoperazone + challenge,,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,TNP-2092,vancomycin,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,9,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,500,3500,500,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,,10,,Clostridium difficile infection,positive,,C57/B6,F,,6-8 weeks,,,mouse,,cefoperazone + challenge,,cumulative mortality,F,t,,ATCC 43255,,,,,,,,,,,,metronidazole 20 mg/kg,TNP-2092,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,acute,10,0,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,p,,HUC 2-4,1000000,CFU,N/A,10^6,,,,,,,,saline control,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,9,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,p,,HUC 2-4,1000000,CFU,N/A,10^6,1000,7000,1000,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,7,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,1000,7000,1000,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/31849218,31849218,31849218.txt,TRUE,2020,,10,,Clostridium difficile infection,positive,,C57/B6,F,,6-8 weeks,,,mouse,,cefoperazone + challenge,,cumulative mortality,F,t,,ATCC 43255,,,,,,,,,,,,vancomycin 20mg/kg,TNP-2092,superior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,7,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,1500,10500,1500,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,2,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,210,1050,210,mg/kg,QD,5,,metronidazole,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,7,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,p,,HUC 2-4,1000000,CFU,N/A,10^6,500,3500,500,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,9,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,t,,HUC 2-4,1000000,CFU,N/A,10^6,500,3500,500,mg/kg,QD,7,,GT160-246,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/11451694,11451694,11451694.txt,TRUE,2001,sustained,10,0,C. difficile disease,positive,N/A,N/A,N/A,N/A,N/A,N/A,N/A,hamster,,challenge+clindamycin,,cumulative mortality,T,p,,HUC 2-4,1000000,CFU,N/A,10^6,,,,,,,,saline control,Saline (control),equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,0,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,,,,,,,,control,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32066975,32066975,32066975.txt,FALSE,2020,,6,,Clostridioides difficile infection,positive,,UC-HMA,M/F,,,,,mouse,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,VPI 10463,,,,,,,,,,,,human microbiota-associated,Antibiotics,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32165071,32165071,32165071.txt,TRUE,2020,,4,,Clostridioides difficile infection.,positive,,C57BL/6J,F,,,,,mouse,,clindamycin + challenge,clindamycin + challenge,gut microflora depopulation,T,t,,BI/NAP1/027,,,,,,,,,,,,vancomycin,fidaxomicin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32165071,32165071,32165071.txt,TRUE,2020,,4,,Clostridioides difficile infection.,positive,,C57BL/6J,F,,,,,mouse,,clindamycin + challenge,clindamycin + challenge,gut microflora depopulation,T,t,,BI/NAP1/027,,,,,,,,,,,,fidaxomicin,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,100,300,50,mg/kg,BID,3,,vancomycin,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,3,1,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,12.5,37.5,6.25,mg/kg,BID,3,,359E,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,,6,,Clostridioides difficile,positive,,C57BL/6J,M/F,,5 weeks,,,mouse,,cefoperazone + challenge,,weight loss,F,t,,630,,,,,,,,,,,,salicylanilides,Negative Control,superior,superior,2nd pass,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,,6,,Clostridioides difficile,positive,,C57BL/6J,M/F,,5 weeks,,,mouse,,cefoperazone + challenge,,weight loss,F,t,,630,,,,,,,,,,,,salicylanilides,vancomycin,inferior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32482070,32482070,32482070.txt,TRUE,2020,,6,,Clostridioides difficile,positive,,C57BL/6J,M/F,,5 weeks,,,mouse,,cefoperazone + challenge,,weight loss,F,t,,630,,,,,,,,,,,,vancomycin,salicylanilides,superior,inferior,2nd pass,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,5,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,25,75,12.5,mg/kg,BID,3,,359E,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,50,150,25,mg/kg,BID,3,,359E,vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,100,300,50,mg/kg,BID,3,,359E,control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,12.5,37.5,6.25,mg/kg,BID,3,,MorE-DCBG (362E),vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,25,75,12.5,mg/kg,BID,3,,MorE-DCBG (362E),control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,10,2,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,Negative Control,FMT-FD,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,50,150,25,mg/kg,BID,3,,MorE-DCBG (362E),vancomycin,equivalent,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22203600,22203600,22203600.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,F,N/A,N/A,85,80-90g,hamster,"selectively inhibits the replication-specific DNA 
 polymerase of Clostridium difficile",clindamycin+challenge,,cumulative mortality,T,t,87,VPI 10463,10000000,CFU,spores,10^7,100,300,50,mg/kg,BID,3,,MorE-DCBG (362E),control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,11,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,FMT-G10,FMT-G80,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,11,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,FMT-G10,FMT-FD,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,6,2,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,0.03,0.15,0.03,mg/kg,QD,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,6,3,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,0.3,1.5,0.3,mg/kg,QD,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,12,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,FMT-G80,FMT-G10,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,12,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,FMT-G80,FMT-FD,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,6,6,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,3,15,3,mg/kg,QD,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,14,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,FMT-FD,FMT-G10,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32501140,32501140,32501140.txt,TRUE,2020,acute,20,14,Clostridioides difficile infection,positive,,C57BL/6,F,,6-7 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,F,t,,R20291 (027),,,,,,,,,,,,FMT-FD,FMT-G80,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32727857,32727857,32727857.txt,FALSE,2020,,NA,,C. difficile,positive,,NA,M/F,,,,,mouse,,clindamycin + challenge,,microbiome diversity,F,p,,C. difficile 2015,,,,,,,,,,,,seven simplified communities in a humanized microbiota,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin,MP-G4,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin,vancomycin+MP-G4,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,MP-G4,Positive Control,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,MP-G4,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,MP-G4,vancomycin+MP-G4,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin+MP-G4,Positive Control,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin+MP-G4,MP-G4,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32775131,32775131,32775131.txt,TRUE,2020,,6,,Clostridioides difficile infection,positive,,C5/BL/6 J,F,,,,,mouse,,oral challenge with spores.,,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin+MP-G4,vancomycin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32786277,32786277,32786277.txt,TRUE,2020,,10,,Clostridioides difficile,positive,,C57BL/6,F,,,,,mouse,,"kanamycin (0.4 mg L1), gentamicin (0.035 mg L1), colistin (850 U mL1), metronidazole (0.215 mg L1), and vancomycin (0.045 mg L1) in sterile drinking water containing 5% sucrose for 3 days, followed by 2 days of regular water. Subsequently, mice were given a 10 mg/kg intraperitoneal injection of clindamycin.",,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,2-(4-(3-(trifluoromethoxy)phenoxy)picolinamido)benzo[d]oxazole-5-carboxylate,equivalent,equivalent,NA,doesn't look equivalent but said not significant,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32786277,32786277,32786277.txt,TRUE,2020,,10,,Clostridioides difficile,positive,,C57BL/6,F,,,,,mouse,,"kanamycin (0.4 mg L1), gentamicin (0.035 mg L1), colistin (850 U mL1), metronidazole (0.215 mg L1), and vancomycin (0.045 mg L1) in sterile drinking water containing 5% sucrose for 3 days, followed by 2 days of regular water. Subsequently, mice were given a 10 mg/kg intraperitoneal injection of clindamycin.",,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,2-(4-(3-(trifluoromethoxy)phenoxy)picolinamido)benzo[d]oxazole-5-carboxylate,equivalent,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32786277,32786277,32786277.txt,TRUE,2020,,10,,Clostridioides difficile,positive,,C57BL/6,F,,,,,mouse,,"kanamycin (0.4 mg L1), gentamicin (0.035 mg L1), colistin (850 U mL1), metronidazole (0.215 mg L1), and vancomycin (0.045 mg L1) in sterile drinking water containing 5% sucrose for 3 days, followed by 2 days of regular water. Subsequently, mice were given a 10 mg/kg intraperitoneal injection of clindamycin.",,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,vancomycin,equivalent,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32786277,32786277,32786277.txt,TRUE,2020,,10,,Clostridioides difficile,positive,,C57BL/6,F,,,,,mouse,,"kanamycin (0.4 mg L1), gentamicin (0.035 mg L1), colistin (850 U mL1), metronidazole (0.215 mg L1), and vancomycin (0.045 mg L1) in sterile drinking water containing 5% sucrose for 3 days, followed by 2 days of regular water. Subsequently, mice were given a 10 mg/kg intraperitoneal injection of clindamycin.",,cumulative mortality,T,t,,ATCC 43255,,,,,,,,,,,,vancomycin,equivalent,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Lr+Dm-Water,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Lr,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Water,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Water,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Water,Lr+Dm-Maltose,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Water,Lr,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Lr+Dm-Maltose,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,t,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Lr+Dm-Water,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,p,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,p,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,p,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr+Dm-Maltose,Lr,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,p,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Positive Control,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,p,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/32954922,32954922,32954922.txt,TRUE,2020,,14,,C. difficile,positive,,NA,NA,,,,,mouse,,clindamycin,,cumulative mortality,F,p,,VPI 10463 (ATCC 43255,,,,,,,,,,,,Lr,Lr+Dm-Maltose,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,2,Clostridioides difficile infection,positive,,C57BL/6,F,,6 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,ronidazole,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,2,Clostridioides difficile infection,positive,,C57BL/6,F,,6 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,ronidazole,metronidazole 1 mg/kg,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,2,Clostridioides difficile infection,positive,,C57BL/6,F,,6 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,ronidazole,vancomycin 10 mg/kg,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,6,5,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,100,500,50,mg/kg,BID,5,,vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,6,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,,,,,,,,Negative Control,fidaxomicin 3 mg/kg,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,0,Clostridioides difficile infection,positive,,C57BL/6,F,,6 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,metronidazole 1 mg/kg,ronidazole,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,6,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,0.03,0.15,0.03,mg/kg,QD,5,,fidaxomicin,vancomycin 100 mg/kg,eqivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,6,1,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,0.3,1.5,0.3,mg/kg,QD,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33045352,33045352,33045352.txt,TRUE,2020,acute,10,10,Clostridioides difficile infection,positive,,C57BL/6,F,,6 weeks,,,mouse,,kanamycin+gentamicin+colistin+metronidazole+vancomycin+clindamycin+challenge,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,vancomycin 10 mg/kg,ronidazole,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33083738,33083738,33083738.txt,TRUE,2020,,5,,Clostridioides difficile,positive,,multiple,M/F,,,,,mouse,,C. diff spores,,cumulative mortality,T,t,,NA,,,,,,,,,,,,LELN-LS,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33083738,33083738,33083738.txt,TRUE,2020,,5,,Clostridioides difficile,positive,,multiple,M/F,,,,,mouse,,C. diff spores,,cumulative mortality,T,t,,NA,,,,,,,,,,,,LELN-LS,LS,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33083738,33083738,33083738.txt,TRUE,2020,,5,,Clostridioides difficile,positive,,multiple,M/F,,,,,mouse,,C. diff spores,,cumulative mortality,T,t,,NA,,,,,,,,,,,,LS,Negative Control,equivalent,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33083738,33083738,33083738.txt,TRUE,2020,,5,,Clostridioides difficile,positive,,multiple,M/F,,,,,mouse,,C. diff spores,,cumulative mortality,T,t,,NA,,,,,,,,,,,,LS,LELN-LS,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,6,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,30000,N/A,spores,3x10^4,,,,,,,,Negative Control,vancomycin 100 mg/kg,eqivalent,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,5,5,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,2,10,1,mg/kg,BID,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130,PCD130 + 027,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130,PCD182,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130,PCD182 + 027,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130 + 027,PCD130,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130 + 027,PCD182,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD130 + 027,PCD182 + 027,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,5,1,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,1,1,1,mg/kg,QD,1,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182,PCD130,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182,PCD130 + 027,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182,PCD182 + 027,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182 + 027,PCD130,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182 + 027,PCD130 + 027,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33202811,33202811,33202811.txt,TRUE,2020,,9,,Clostridioides difficile,positive,,Golden Syrian,F,,adult,,,hamster,,challenge,,cumulative mortality,F,p,,CD13-12 (027),,,,,,,,,,,,PCD182 + 027,PCD182,inferior,inferior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,acute,5,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,,,,,,,,Negative Control,fidaxomicin 3 mg/kg,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,5,2,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,2,10,1,mg/kg,BID,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,5,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,1,1,1,mg/kg,QD,1,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,,20,,Clostridioides difficile,positive,SPF,Golden Syrian,M,,4-5 week,,,hamster,,challenge + clindamycin,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,OPS-2071,vancomycin,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,,20,,Clostridioides difficile,positive,SPF,Golden Syrian,M,,4-5 week,,,hamster,,challenge + clindamycin,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,OPS-2071,fidaxomicin,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,,20,,Clostridioides difficile,positive,SPF,Golden Syrian,M,,4-5 week,,,hamster,,challenge + clindamycin,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,OPS-2071,Negative Control,superior,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,,20,,Clostridioides difficile,positive,SPF,Golden Syrian,M,,4-5 week,,,hamster,,challenge + clindamycin,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,vancomycin,OPS-2071,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33495229,33495229,33495229.txt,TRUE,2021,,20,,Clostridioides difficile,positive,SPF,Golden Syrian,M,,4-5 week,,,hamster,,challenge + clindamycin,,cumulative mortality,T,t,,VPI 10463,,,,,,,,,,,,fidaxomicin,OPS-2071,equivalent,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,6,3,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,3,15,3,mg/kg,QD,5,,fidaxomicin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,6,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,100,500,50,mg/kg,BID,5,,vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/29439962,29439962,29439962.txt,TRUE,2018,sustained,5,0,Clostridium difficile infection,positive,N/A,Golden Syrian,M,N/A,N/A,N/A,N/A,hamster,,clindamycin+challenge,clindamycin+challenge,cumulative mortality,T,t,27,2009155,40000,N/A,spores,4x10^4,,,,,,,,Negative Control,fidaxomicin 3 mg/kg,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22869573,22869573,22869573.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,50000000,CFU,N/A,5x10^7,300,1500,150,mg/kg,BID,5,,metronidazole,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22869573,22869573,22869573.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,50000000,CFU,N/A,5x10^7,100,500,50,mg/kg,BID,5,,RBx 14255,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22869573,22869573,22869573.txt,TRUE,2012,acute,6,6,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,50000000,CFU,N/A,5x10^7,100,500,50,mg/kg,BID,5,,Vancomycin,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22869573,22869573,22869573.txt,TRUE,2012,sustained,6,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,50000000,CFU,N/A,5x10^7,300,1500,150,mg/kg,BID,5,,metronidazole,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22869573,22869573,22869573.txt,TRUE,2012,sustained,6,3,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,50000000,CFU,N/A,5x10^7,100,500,50,mg/kg,BID,5,,RBx 14255,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/22869573,22869573,22869573.txt,TRUE,2012,sustained,6,0,C. difficile disease,positive,N/A,Golden Syrian,N/A,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,,cumulative mortality,F,t,12,ATCC 43596,50000000,CFU,N/A,5x10^7,100,500,50,mg/kg,BID,5,,Vancomycin,Negative Control,superior,equivalent,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,acute,20,20,Clostridioides difficile infections,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,T,t,428,VA11,7500000,CFU,N/A,7.5x10^6,20,100,20,mg/kg,QD,5,,vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,acute,20,1,Clostridioides difficile infections,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,T,t,428,VA11,7500000,CFU,N/A,7.5x10^6,,,,,,,,Negative Control,vancomycin,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,sustained,20,14,Clostridioides difficile infections,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,T,t,428,VA11,7500000,CFU,N/A,7.5x10^6,20,100,20,mg/kg,QD,5,,vancomycin,Negative Control,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,sustained,20,0,Clostridioides difficile infections,positive,N/A,Golden Syrian,M,N/A,N/A,90,80-100g,hamster,,clindamycin+challenge,clindamycin+challenge,survival,T,t,428,VA11,7500000,CFU,N/A,7.5x10^6,,,,,,,,Negative Control,vancomycin,superior,NA,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,10,10,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,10,50,10,mg/kg,QD,5,,SMT19969,vancomycin,equivalent,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,20,100,20,mg/kg,QD,5,,SMT19969,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,20,100,20,mg/kg,QD,5,,Vancomycin,"SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]",equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,50,250,50,mg/kg,QD,5,,SMT19969,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,10,0,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,10,50,10,mg/kg,QD,5,,SMT19969,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,20,11,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,20,100,20,mg/kg,QD,5,,SMT19969,"SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]",equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,20,11,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,40,200,20,mg/kg,BID,5,,Vancomycin,"SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]",equivalent,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33588433,33588433,33588433.txt,TRUE,2021,,9,,Clostridioides difficile infection,positive,,NA,NA,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,NA,,,,,,,,,,,,IgA (sIgA) + subtherapeutic vancomycin,Negative Control,superior,superior,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33588433,33588433,33588433.txt,TRUE,2021,,9,,Clostridioides difficile infection,positive,,NA,NA,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,NA,,,,,,,,,,,,IgA (sIgA) + subtherapeutic vancomycin,vancomycin,superior,superior,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33588433,33588433,33588433.txt,TRUE,2021,,9,,Clostridioides difficile infection,positive,,NA,NA,,,,,hamster,,clindamycin + challenge,,cumulative mortality,T,t,,NA,,,,,,,,,,,,vancomycin,Negative Control,equivalent,equivalent,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33588433,33588433,33588433.txt,TRUE,2021,,9,,Clostridioides difficile infection,positive,,NA,NA,,,,,hamster,,antibiotcs + challenge,,cumulative mortality,T,t,,NA,,,,,,,,,,,,vancomycin,IgA (sIgA) + subtherapeutic vancomycin,inferior,inferior,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/3372017,3372017,3372017.txt,TRUE,1988,,10,,Clostridium difficile infection,positive,,NA,NA,,,,,mouse,,antibiotcs + challenge,,enterotoxin production,F,t,,"VPI 10463 and Mara (5, 15)",,,,,,,,,,,,S. boulardii protease,Negative Control,equivalent,superior,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,,10,,Clostridioides difficile infections,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,C. diff counts in cecal tissues,T,t,,VA11,,,,,,,,,,,,auranofin,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,,10,,Clostridioides difficile infections,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,C. diff counts in cecal tissues,T,t,,VA11,,,,,,,,,,,,auranofin,vancomycin,inferior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,20,14,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,challenge+clindamycin,cumulative mortality,T,t,27,VA5,894206,CFU,N/A,5.11 to 6.22 log10,50,250,50,mg/kg,QD,5,,SMT19969,vancomycin,equivalent,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,10,9,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,10,50,10,mg/kg,QD,5,,SMT19969,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33782498,33782498,33782498.txt,TRUE,2021,,10,,Clostridioides difficile infections,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,,C. diff counts in cecal tissues,T,t,,VA11,,,,,,,,,,,,vancomycin,auranofin,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,20,19,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,20,100,20,mg/kg,QD,5,,SMT19969,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,20,20,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,20,100,20,mg/kg,QD,5,,Vancomycin,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,acute,20,19,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,50,250,50,mg/kg,QD,5,,SMT19969,Negative Control,superior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,cholestyramine,Negative Control,superior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,cholestyramine,vancomycin,inferior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,cholestyramine,vancomycin + cholestyramine,inferior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin,Negative Control,superior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin,cholestyramine,superior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin,vancomycin + cholestyramine,superior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin + cholestyramine,Negative Control,superior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin + cholestyramine,cholestyramine,superior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7365273,7365273,7365273.txt,TRUE,1980,,20,,Clostridium difficile,positive,,Golden Syrian,M,,,,,hamster,,clindamycin + challenge,clindamycin + challenge,cumulative mortality,F,t,,NA,,,,,,,,,,,,vancomycin + cholestyramine,vancomycin,inferior,NA,can't access,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7380566,7380566,7380566.txt,TRUE,1980,,NA,,Clostridium difficile,positive,anexic,CD1,M,,,,,mouse,,germfree + challenge,,spore count,F,t,,HUC2-4,,,,,,,,,,,,vancomycin,clindamycin,superior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7380566,7380566,7380566.txt,TRUE,1980,,NA,,Clostridium difficile,positive,anexic,CD1,M,,,,,mouse,,germfree + challenge,,spore count,F,t,,HUC2-4,,,,,,,,,,,,clindamycin,vancomycin,superior,equivalent,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,10,8,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,10,50,10,mg/kg,QD,5,,SMT19969,vancomycin,inferior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,20,18,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,20,100,20,mg/kg,QD,5,,SMT19969,vancomycin,inferior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,20,12,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,20,100,20,mg/kg,QD,5,,Vancomycin,"SMT19969 [2,2'-bis(4-pyridyl)3H,3'-H 5,5-bibenzimidazole]",superior,inferior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/25022586,25022586,25022586.txt,TRUE,2014,sustained,20,19,C. difficile disease,positive,N/A,Golden Syrian,M,N/A,N/A,100,80-120g,hamster,,challenge+clindamycin,,cumulative mortality,T,t,428,VA11,752846,CFU,N/A,5.44 to 6.09 log10,50,250,50,mg/kg,QD,5,,SMT19969,vancomycin,inferior,superior,,Y,TRUE
https://pubmed.ncbi.nlm.nih.gov/33037214,33037214,33037214.txt,FALSE,2020,,NA,,Clostridioides difficile,positive,,C57BL/6N,F,,,,,mouse,,antibiotic-treated,,Optical Density (?),F,t,,NA,,,,,,,,,,,,five-member consortium of sialic acid and N-acetylglucosamine utilizers,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/33037214,33037214,33037214.txt,FALSE,2020,,NA,,Clostridioides difficile,positive,,C57BL/6N,F,,,,,mouse,,antibiotic-treated,,Optical Density (?),F,t,,NA,,,,,,,,,,,,five-member consortium of sialic acid and N-acetylglucosamine utilizers,Positive Control,equal,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/7001883,7001883,7001883.txt,TRUE,1980,,NA,,Clostridium difficile,positive,anexic,axenic,NA,,,,,mouse,,antibiotic-treated,,spore counts,F,t,,NA,,,,,,,,,,,,human fecal flora,Negative Control,superior,NA,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/8510136,8510136,8510136.txt,TRUE - NOT TESTING SAME THING,1993,,,,Clostridium difficile,positive,,axenic,NA,,,,,mouse,,,,,,,,VPI 10463,,,,,,,,,,,,serogroup F strains,,,,Pass 2 (NA),,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,vancomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,metronidazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,cholestyramine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,Lomotil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,vancomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,metronidazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium  difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,cholestyramine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,Lomotil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,vancomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,metronidazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,cholestyramine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,hamster,,clindamycin,,,,,,,,,,,,,,,,,,Lomotil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,vancomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,metronidazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,cholestyramine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,Lomotil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,vancomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,metronidazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,cholestyramine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,Lomotil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,vancomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,metronidazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,cholestyramine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/760500,760500,760500.txt,TRUE - NOT FOUND,1979,,,,Clostridium  difficile,positive,,,,,,,,Corticosteroids,,clindamycin,,,,,,,,,,,,,,,,,,Lomotil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29998951,29998951,29998951.txt,TRUE - JAPANESE,2018,,,,Clostridium difficile (,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Bezlotoxumab,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29998951,29998951,29998951.txt,TRUE - JAPANESE,2018,,,,Clostridium difficile (,positive,,,,,,,,rat,,,,,,,,,,,,,,,,,,,,Bezlotoxumab,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/6742589,6742589,6742589.txt,TRUE - NOT FOUND,1984,,49,,Clostridium difficile,positive,,gnotobiotic,NA,,,,,mouse,,,,,,,,,,,,,,,,,,,,cecal content of a healthy young hare,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1488767,1488767,1488767.txt,FALSE,1992,,,,C. difficile disease,positive,,BALB/c,,,,,,mouse,,orogastric toxin A and toxin B concentration 10^3.6,,cumulative mortality,F,p,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1488767,1488767,1488767.txt,FALSE,1992,,,,C. difficile disease,positive,,BALB/c,,,,,,mouse,,orogastric toxin A and toxin B concentration 10^2.8,,cumulative mortality,F,p,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/1488767,1488767,1488767.txt,FALSE,1992,,,,C. difficile disease,positive,,BALB/c,,,,,,mouse,,orogastric toxin A and toxin B concentration 10^2.3,,cumulative mortality,F,p,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,control,equivalent,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Water movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces boulardii,Positive control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Water movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces boulardii,Toxin A (negative) control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Water movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces boulardii,Saccharomyces cerevisiae,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Water movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces cerevisiae,Positive control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Water movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces cerevisiae,Toxin A (negative) control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Water movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces cerevisiae,Saccharomyces boulardii,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Sodium movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces boulardii,Positive control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Sodium movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces boulardii,Saccharomyces cerevisiae,equivalent,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Sodium movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces boulardii,Toxin A (negative) control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Sodium movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces cerevisiae,Positive control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Sodium movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces cerevisiae,Saccharomyces boulardii,equivalent,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/9753273,9753273,9753273.txt,FALSE,1998,,5,,C. difficile disease,positive,,Sprague-Dawley,M,,,,,rat,,toxin A,,Sodium movment from blood to lumen,F,p,,NA,,,,,,,,,,,,Saccharomyces cerevisiae,Toxin A (negative) control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,total intensital lgA,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Positive control,superior,,"this looks wrong, but the sb was actually superior to the control",Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,total intensital lgA,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Toxin A (negative) control,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,total intensital lgA,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Saccharomyces boulardii and Toxin A,superior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,intestinal IgA anti-toxin A level,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Positive control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,intestinal IgA anti-toxin A level,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Toxin A (negative) control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,intestinal IgA anti-toxin A level,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Saccharomyces boulardii and Toxin A,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,specific anti-toxin A lgA : total intenstial lgA ratio ,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Positive control,equivalent,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,specific anti-toxin A lgA : total intenstial lgA ratio ,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Toxin A (negative) control,inferior,,,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254650,11254650,11254650.txt,FALSE,2001,,15,,Clostridium difficile,positive,,BALB/c,NA,,,,,mouse,,toxin A gavage,,specific anti-toxin A lgA : total intenstial lgA ratio ,F,t,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,Saccharomyces boulardii and Toxin A,inferior,,this paper was terrible :(,Y,FALSE
https://pubmed.ncbi.nlm.nih.gov/16816386,16816386,16816386.txt,FALSE,2006,,,,C. difficile disease,positive,,NA,NA,,,,,mouse,"S. boulardii inhibits C. difficile toxin 
 A-associated enteritis by blocking the activation of Erk1/2 MAP kinases.",ileal loop + toxin A,,,,p,,,,,,,,,,,,,,Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1913342,1913342,1913342.txt,FALSE,1991,,,,Clostridium difficile,positive,,gnotobiotic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,viable and nonviable Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21393125,21393125,21393125.txt,FALSE,2011,,,,,positive,,,,,,,,mouse,,intraperitoneally injected with 0.2 mL of filter-sterilized C. difficile culture supernatant (CDT preparation).,,,,,,,,,,,,,,,,,,intravenous immunoglobulin (IVIg),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/2200843,2200843,2200843.txt,FALSE,1990,,,,Clostridium difficile,positive,,axenic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22264229,22264229,22264229.txt,FALSE,2012,,,,Clostridium difficile toxin-induced,positive,,,,,,,,rabbit,,toxin A-induced,,,,,,,,,,,,,,,,,,"combination therapy with ATL 370, an adenosine A2A receptor agonist, and alanyl-glutamine",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22264229,22264229,22264229.txt,FALSE,2012,,,,Clostridium difficile toxin-induced,positive,,,,,,,,mouse,,toxin A-induced,,,,,,,,,,,,,,,,,,"combination therapy with ATL 370, an adenosine A2A receptor agonist, and alanyl-glutamine",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24590475,24590475,24590475.txt,FALSE,2014,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,VPI 10463,,,,,,,,,,,,Tigecycline,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25059277,25059277,25059277.txt,FALSE,2014,,,,Clostridium difficile (,positive,,C57BL/6,,,,,,mouse,,,,,,,,NAP1/027,,,,,,,,,,,,synbiotic formulation,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25800047,25800047,25800047.txt,FALSE,2015,,,,Clostridium difficile infections,positive,,C57BL/6,,,,,,mouse,,,,,,,,VPI 10463,,,,,,,,,,,,Bacillus amyloliquefaciens,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25800047,25800047,25800047.txt,FALSE,2015,,,,Clostridium difficile infections,positive,,C57BL/6,,,,,,mouse,,,,,,,,VPI 10463,,,,,,,,,,,,Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25805751,25805751,25805751.txt,FALSE,2015,,,,,positive,,NF-B reporter,,,,,,mouse,,antibiotic-associated,,,,,,,,,,,,,,,,,,proton pump inhibitors (PPIs),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27180007,27180007,27180007.txt,FALSE,2016,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,kefir,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27514478,27514478,27514478.txt,FALSE,2016,,,,C. difficile infection (CDI),positive,,,,,,,,hamster,,,,,,,,VPI10463,,,,,,,,,,,,Saccharomyces boulardii CNCM I-745 (S.b),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27514478,27514478,27514478.txt,FALSE,2016,,,,C. difficile infection (CDI),positive,,,,,,,,hamster,,,,,,,,"outbreak-associated strains  ribotype 017, 027, and 078",,,,,,,,,,,,Saccharomyces boulardii CNCM I-745 (S.b),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28217763,28217763,28217763.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,tigecycline,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28217763,28217763,28217763.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,ceftriaxone,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28217763,28217763,28217763.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,piperacillin-tazobactam,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28217763,28217763,28217763.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,linezolid,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28623367,28623367,28623367.txt,FALSE,2017,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,hyperimmune bovine colostrum (HBC),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29385239,29385239,29385239.txt,FALSE,2018,,,,Clostridium difficile (,positive,,,,,,,,mouse,,clindamycin,,,,,,,,,,,,,,,,,,Faecalibacterium prausnitzii (FP),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29385239,29385239,29385239.txt,FALSE,2018,,,,Clostridium difficile (,positive,,,,,,,,mouse,,clindamycin,,,,,,,,,,,,,,,,,,potato starch,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588(CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,hamsters,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,clindamycin phosphate,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,clindamycin phosphate,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,VPI10463,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588(CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29967595,29967595,29967595.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Wistar,,,,,,rats,,received 10% egg white dissolved in drinking water for 1 week ad libitum following intramuscular administration of 200 mg/kg MNZ twice a day for 3 days,,,,,,KY34,,,,,,,,,,,,Clostridium butyricum MIYAIRI 588 (CBM),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/3815159,3815159,3815159.txt,FALSE,1986,,,,Clostridium difficile infection.,positive,,gnotobiotic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8462799,8462799,8462799.txt,FALSE,1993,,,,,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8462799,8462799,8462799.txt,FALSE,1993,,,,,positive,,,,,,,,rat,,ileal loop,,,,,,,,,,,,,,,,,,Saccharomyces boulardii,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8834883,8834883,8834883.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,Anti-C. difficile bovine immunoglobulin concentrate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8834883,8834883,8834883.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rat,,ileal loop,,,,,,,,,,,,,,,,,,Anti-C. difficile bovine immunoglobulin concentrate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8945570,8945570,8945570.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,S. boulardii protease,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8945570,8945570,8945570.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rat,,ileal loop,,,,,,,,,,,,,,,,,,S. boulardii protease,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,112G6,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,112G6,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,2.00E+15,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,2.00E+15,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,"3B4,",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,"3B4,",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,49C4,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,49C4,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,mouse,antibody,,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,112G6,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,112G6,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,2.00E+15,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,2.00E+15,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,"3B4,",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,"3B4,",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,49C4,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,49C4,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1916231,1916231,1916231.txt,FALSE,1991,,,,C. difficile disease,positive,,,,,,,,rabbit,antibody,ileal loop + toxin A,,,,,,,,,,,,,,,,,,37B5,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1728517,1728517,1728517.txt,FALSE,1992,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,t,,strain 1010,,,,,,,,,,,,yogurt,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9199444,9199444,9199444.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin A intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,BWA4C,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9199444,9199444,9199444.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin A intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,nordihydroguaiaretic acid,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9199444,9199444,9199444.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin A intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,mepacrine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9199444,9199444,9199444.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin A intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,dexamethasone,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9199444,9199444,9199444.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin A intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9199444,9199444,9199444.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin A intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,platelet-activating factor antagonist BN52021,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9227329,9227329,9227329.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin B intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,MK886 (a lipoxygenase inhibitor),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9227329,9227329,9227329.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin B intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,NDGA (a dual cyclo- and lipoxygenase inhibitor),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9227329,9227329,9227329.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin B intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,dexamethasone,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9227329,9227329,9227329.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin B intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9227329,9227329,9227329.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,toxin B intraperitoneally,,,,p,,VPI 10463,,,,,,,,,,,,BN52021,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9277411,9277411,9277411.txt,FALSE,1997,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,ileal loop + toxin A,,,,p,,VPI 10463,,,,,,,,,,,,recombinant human IL-11 (rhIL-11),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9345763,9345763,9345763.txt,FALSE,1997,,,,C. difficile disease,positive,,BALB/c,,,,,,mouse,,toxin A subcutaneously,,,,p,,VPI 10463,,,,,,,,,,,,recombinant protein (REP231),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9414971,9414971,9414971.txt,FALSE,1997,,,,C. difficile disease,positive,,Sprague-Dawley,,,,,,rat,,jejeunum loop + toxin A,,,,t,,,,,,,,,,,,,,Antisecretory factor (AF),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9573084,9573084,9573084.txt,FALSE,1998,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,p,,"ATCC 43596, ATCC 43255, or VPI 7698",,,,,,,,,,,,avian antibodies against recombinant epitopes of toxin A and toxin B,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9573084,9573084,9573084.txt,FALSE,1998,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,p,,"ATCC 43596, ATCC 43255, or VPI 7698",,,,,,,,,,,,avian antibodies against recombinant epitopes of toxin A and toxin B,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9573084,9573084,9573084.txt,FALSE,1998,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,t,,"ATCC 43596, ATCC 43255, or VPI 7698",,,,,,,,,,,,avian antibodies against recombinant epitopes of toxin A and toxin B,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9573084,9573084,9573084.txt,FALSE,1998,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,t,,"ATCC 43596, ATCC 43255, or VPI 7698",,,,,,,,,,,,avian antibodies against recombinant epitopes of toxin A and toxin B,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/10079105,10079105,10079105.txt,FALSE,1999,,,,C. difficile disease,positive,,,,,,,,rat,neurotensin receptor antagonist,colonic loop + toxin A,,,,p,,,,,,,,,,,,,,"SR-48,692",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/11254479,11254479,11254479.txt,FALSE,2001,,,,C. difficile disease,positive,,Wistar,,,,,,rat,,ileal loop + toxin A,,,,t,,VPI 10463,,,,,,,,,,,,dexamethasone,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/14616550,14616550,14616550.txt,FALSE,2003,,,,C. difficile disease,positive,,Sprague-Dawley,,,,,,rat,"tolerance was probably mediated by AF induced via action of 
 cholera toxin on the enteric nervous and immune system",intestinal loop + toxin A,,,,t,,,,,,,,,,,,,,antisecretory factor,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/15899406,15899406,15899406.txt,FALSE,2005,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,p,,,,,,,,,,,,,,anti-surface layer protein (SLP) antibodies,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17639289,17639289,17639289.txt,FALSE,2007,,,,C. difficile disease,positive,,C57BL6Cr,,,,,,mouse,p38 inhibitor,ileal loop + toxin A,,,,t,,ATCC9689,,,,,,,,,,,,SB203580,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17805968,17805968,17805968.txt,FALSE,2008,,,,C. difficile disease,positive,,swiss,,,,,,mouse,"L-selectin 
 blocker",toxin A-induced,,,,t,,VPI 10463,,,,,,,,,,,,fucoidin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/20347817,20347817,20347817.txt,FALSE,2010,,,,C. difficile disease,positive,,,,,,,,mouse,,ileal loop + toxin A + toxin B,,,,p,,NAP-1/027,,,,,,,,,,,,dimethyloxaloylglycine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/20696758,20696758,20696758.txt,FALSE,2010,,,,C. difficile disease,positive,,CD1,,,,,,mouse,"inhibitor of 
 the HDAC6 tubulin deacetylase",ileal loop + toxin A,,,,p,,VPI 10463,,,,,,,,,,,,trichostatin A (TSA),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21131421,21131421,21131421.txt,FALSE,2011,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,ileal loop + toxin A,,,,p,,,,,,,,,,,,,,CX3CL1/FKN,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21131421,21131421,21131421.txt,FALSE,2011,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,ileal loop + toxin A,,,,p,,,,,,,,,,,,,,tin-protoporphyrin-IX,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21807975,21807975,21807975.txt,FALSE,2011,,,,C. difficile disease,positive,,CD1,,,,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,,,t,,VPI 10463,,,,,,,,,,,,coprisin analogue,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21857653,21857653,21857653.txt,FALSE,2011,,,,C. difficile disease,positive,,,,,,,,mouse,,ileal loop + toxin A,,,,t,,,,,,,,,,,,,,InsP(6),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21857653,21857653,21857653.txt,FALSE,2011,,,,C. difficile disease,positive,,,,,,,,mouse,,ileal loop + toxin A,,,,t,,,,,,,,,,,,,,GNSO,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22733075,22733075,22733075.txt,FALSE,2012,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,t,,VPI 10463,,,,,,,,,,,,MBX-500,vancomycin,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22733075,22733075,22733075.txt,FALSE,2012,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,t,,VPI 10463,,,,,,,,,,,,MBX-500,vancomycin,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22733075,22733075,22733075.txt,FALSE,2012,,,,Recurrent C. difficile infection,positive,,Golden Syrian,,,,,,hamster,,clindamycin+challenge,,,,t,,VPI 10463,,,,,,,,,,,,MBX-500,vancomycin,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22733075,22733075,22733075.txt,FALSE,2012,,,,Recurrent C. difficile infection,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,t,,VPI 10463,,,,,,,,,,,,MBX-500,vancomycin,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23045479,23045479,23045479.txt,FALSE,2012,,,,C. difficile disease,positive,,white,,,,,,rabbit,A(2B)AR antagonist,ileal loop + toxin A,,,,t,,,,,,,,,,,,,,ATL692,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23045479,23045479,23045479.txt,FALSE,2012,,,,C. difficile disease,positive,,white,,,,,,rabbit,A(2B)AR antagonist,ileal loop + toxin A,,,,t,,,,,,,,,,,,,,PSB1115,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23045479,23045479,23045479.txt,FALSE,2012,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,A(2B)AR antagonist,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,,,t,,VPI 10463,,,,,,,,,,,,ATL801,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23071818,23071818,23071818.txt,FALSE,2012,,,,C. difficile disease,positive,,C57BL/6J,,,,,,mouse,PPAR agonist,"vancomycin,colistin,gentamicin,metronidazole+clindamycin+challenge",,,,p,,VPI 10463,,,,,,,,,,,,pioglitazone,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24023628,24023628,24023628.txt,FALSE,2013,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,p,,,,,,,,,,,,,,CamSA,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24023628,24023628,24023628.txt,FALSE,2013,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,p,,,,,,,,,,,,,,CamSA,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24023628,24023628,24023628.txt,FALSE,2013,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,p,,,,,,,,,,,,,,taurocholate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24023628,24023628,24023628.txt,FALSE,2013,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,p,,,,,,,,,,,,,,ethyl cholate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24023628,24023628,24023628.txt,FALSE,2013,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,p,,,,,,,,,,,,,,chenodeoxycholate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24509250,24509250,24509250.txt,FALSE,2014,,,,C. difficile disease,positive,,CD1,,,,,,mouse,,ileal loop + toxin A,,,,t,,VPI 10463,,,,,,,,,,,,antitoxin sera,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25267665,25267665,25267665.txt,FALSE,2014,,,,C. difficile disease,positive,,,,,,,,pig,,gnotobiotic+challenge,,,,t,,027/NAP1/BI strain UK6,,,,,,,,,,,,tigecycline,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30238771,30238771,30238771.txt,FALSE,2018,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,"kanamycin, gentamicin, colistin, metronidazole, and vancomycin+clindamycin+challenge",,,,p,,R20291,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30238771,30238771,30238771.txt,FALSE,2018,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,cefoperazone +clindamycin+challenge,,,,p,,630,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30356740,30356740,30356740.txt,FALSE,2018,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,clindamycin+challenge,,,,p,,VPI 10463,,,,,,,,,,,,Pediococcus pentosaceus LI05,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30524414,30524414,30524414.txt,FALSE,2018,,,,C. difficile disease,positive,,Golden Syrian,,,,,,hamster,,clindamycin+gentamicin+challenge,,,,p,,VPI 10463,,,,,,,,,,,,Ursodeoxycholic acid (UDCA),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30619112,30619112,30619112.txt,FALSE,2018,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,kanamycin+gentamicin+colistin+MTZ+vancomycin+challenge,,,,p,,VPI 10463,,,,,,,,,,,,B. fragilis strain ZY-312,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30622186,30622186,30622186.txt,FALSE,2019,,,,C. difficile disease,positive,,C57BL/6,,,,,,mouse,,cefoperazone+challenge,,,,p,,M7404,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/11875005,11875005,11875005.txt,FALSE,2002,,,,Clostridium difficile,positive,,SV129/C57black6,,,,,,mouse,,ileal loop + toxin A,intraperitoneally,"ileal fluid accumulation, myeloperoxidase activity",t,p,,VPI 10463,,,,,,,,,,,,Met-RANTES,vehicle,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/12235074,12235074,12235074.txt,FALSE,2002,,12-Oct,,Clostridium difficile,positive,,NMRI,male,,,,,mouse,,toxin A + toxin B oral,oral,stool weight reduction,t,p,,,,,,,,,,,,,,igmesine,vehicle,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/12235074,12235074,12235074.txt,FALSE,2002,,12-Oct,,Clostridium difficile,positive,,NMRI,male,,,,,mouse,,toxin A + toxin B oral,oral,stool weight reduction,t,p,,,,,,,,,,,,,,igmesine,JO 2871,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/12235074,12235074,12235074.txt,FALSE,2002,,12-Oct,,Clostridium difficile,positive,,NMRI,male,,,,,mouse,,toxin A + toxin B oral,oral,stool weight reduction,t,p,,,,,,,,,,,,,,JO 2871,vehicle,,,further combination therapy data with cyclosomatostatin and BMY14802 may also exist,,FALSE
https://pubmed.ncbi.nlm.nih.gov/12235074,12235074,12235074.txt,FALSE,2002,,12-Oct,,Clostridium difficile,positive,,NMRI,male,,,,,mouse,,toxin A + toxin B oral,oral,stool weight reduction,t,p,,,,,,,,,,,,,,JO 2871,igmesine,,,further combination therapy data with cyclosomatostatin and BMY14802 may also exist,,FALSE
https://pubmed.ncbi.nlm.nih.gov/15767259,15767259,15767259.txt,FALSE,2005,,3,,Clostridium difficile,positive,,CD1,male,,,,,mouse,,ileal loop + toxin A,injection,fluid secretion,,p,,VPI 10463,,,,,,,,,,,,SB203580,vehicle,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/15767259,15767259,15767259.txt,FALSE,2005,,3,,Clostridium difficile,positive,,CD1,male,,,,,mouse,,ileal loop,injection,fluid secretion,,p,,VPI 10463,,,,,,,,,,,,NS-398,vehicle,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/15942869,15942869,15942869.txt,FALSE,2005,,,,Clostridium difficile,positive,,gnotobiotic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,S. cerevisiae 905,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/15942869,15942869,15942869.txt,FALSE,2005,,,,Clostridium difficile,positive,,conventional,,,,,,mouse,,,,,,,,,,,,,,,,,,,,S. cerevisiae 905,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/16344056,16344056,16344056.txt,FALSE,2005,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,SB203580,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/16622196,16622196,16622196.txt,FALSE,2006,,,,Clostridium difficile,positive,,,,,,,,mouse,,toxin A-induced,,,,,,,,,,,,,,,,,,ATL 313,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/16622196,16622196,16622196.txt,FALSE,2006,,,,Clostridium difficile,positive,,,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,ATL 313,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17570216,17570216,17570216.txt,FALSE,2007,,,,Clostridium difficile,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,FUT-175,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17570216,17570216,17570216.txt,FALSE,2007,,,,Clostridium difficile,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,FUT-175,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17570216,17570216,17570216.txt,FALSE,2007,,,,Clostridium difficile,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,MPI-0442352,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17570216,17570216,17570216.txt,FALSE,2007,,,,Clostridium difficile,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,MPI-0442352,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17570216,17570216,17570216.txt,FALSE,2007,,,,Clostridium difficile,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,soybean trypsin inhibitor,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/17570216,17570216,17570216.txt,FALSE,2007,,,,Clostridium difficile,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,soybean trypsin inhibitor,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/18094539,18094539,18094539.txt,FALSE,2007,,,,Clostridium difficile,positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,ampicillin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/18094539,18094539,18094539.txt,FALSE,2007,,,,Clostridium difficile,positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,lansoprazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/18693236,18693236,18693236.txt,FALSE,2008,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,one of four strains of C. difficile,,,,,,,,,,,,ampicillin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/18693236,18693236,18693236.txt,FALSE,2008,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,one of four strains of C. difficile,,,,,,,,,,,,piperacillin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/18693236,18693236,18693236.txt,FALSE,2008,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,one of four strains of C. difficile,,,,,,,,,,,,beta-lactamase,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/18693236,18693236,18693236.txt,FALSE,2008,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,one of four strains of C. difficile,,,,,,,,,,,,tazobactam-inactivated oral beta-lactamase,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/1900059,1900059,1900059.txt,FALSE,1991,,,,C. difficile disease,positive,,axenic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,monoclonal antibodies against toxin A,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/19416358,19416358,19416358.txt,FALSE,2009,,,,Clostridium difficile,positive,,,,,,,,mouse,,intestinal loops,,,,,,,,,,,,,,,,,,"yeast, beef and pork extracts",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/20398664,20398664,20398664.txt,FALSE,2010,,,,Clostridium difficile-associated disease (CDAD),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,anakinra,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21115723,21115723,21115723.txt,FALSE,2011,,,,Clostridium difficile-associated disease,positive,,C57BL6,,,,,,mouse,inhibitor of adenosine deaminase,ileal loop,,,,,,,,,,,,,,,,,,EHNA [erythro-9-(2-hydroxy-3-nonyl)-adenine],,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21115723,21115723,21115723.txt,FALSE,2011,,,,Clostridium difficile-associated disease,positive,,C57BL6,,,,,,mouse,inhibitor of adenosine deaminase,ileal loop,,,,,,,,,,,,,,,,,,EHNA [erythro-9-(2-hydroxy-3-nonyl)-adenine],,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21115723,21115723,21115723.txt,FALSE,2011,,,,Clostridium difficile-associated disease,positive,,C57BL6,,,,,,mouse,inhibitor of adenosine deaminase,ileal loop,,,,,,,,,,,,,,,,,,ATL313,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21115723,21115723,21115723.txt,FALSE,2011,,,,Clostridium difficile-associated disease,positive,,C57BL6,,,,,,mouse,inhibitor of adenosine deaminase,ileal loop,,,,,,,,,,,,,,,,,,ATL313,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21245274,21245274,21245274.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,Toll-like receptor 5 (TLR5) agonist,,,,,,,,,,,,,,,,,,,Salmonella-derived flagellin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21314706,21314706,21314706.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,pigs,"lacticin 3147, a broad-spectrum bacteriocin",,,,,,,,,,,,,,,,,,,Lactococcus lactis DPC6520,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,a specific HO-1 inhibitor,toxin A-induced,,,,,,,,,,,,,,,,,,zinc protoporphyrin IX (ZnPP IX),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,a specific HO-1 inhibitor,toxin A-induced,,,,,,,,,,,,,,,,,,zinc protoporphyrin IX (ZnPP IX),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,"a CO 
 
 donor",toxin A-induced,,,,,,,,,,,,,,,,,,zinc protoporphyrin IX (ZnPP IX),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,"a CO 
 
 donor",toxin A-induced,,,,,,,,,,,,,,,,,,zinc protoporphyrin IX (ZnPP IX),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,a specific HO-1 inhibitor,toxin A-induced,,,,,,,,,,,,,,,,,,dimanganese decacarbonyl (DMDC),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,a specific HO-1 inhibitor,toxin A-induced,,,,,,,,,,,,,,,,,,dimanganese decacarbonyl (DMDC),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,"a CO 
 
 donor",toxin A-induced,,,,,,,,,,,,,,,,,,dimanganese decacarbonyl (DMDC),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/21372182,21372182,21372182.txt,FALSE,2011,,,,Clostridium difficile,positive,,,,,,,,mouse,"a CO 
 
 donor",toxin A-induced,,,,,,,,,,,,,,,,,,dimanganese decacarbonyl (DMDC),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22014083,22014083,22014083.txt,FALSE,2011,,,,Clostridium  difficile (,positive,,C57BL/6,,,,,,mouse,,,,,,,,VPI 10463,,,,,,,,,,,,"Bacillus Coagulans GBI-30, 6086 (BC30)",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22760006,22760006,22760006.txt,FALSE,2013,,,,Clostridium difficile infection,positive,,Wild Type,,,,,,mouse,,antibiotic mixture and infected orally with C difficile.,,,,,,,,,,,,,,,,,,mCRAMP,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22760006,22760006,22760006.txt,FALSE,2013,,,,Clostridium difficile infection,positive,,Wild Type,,,,,,mouse,,antibiotic mixture and infected orally with C difficile.,,,,,,,,,,,,,,,,,,mCRAMP,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22760006,22760006,22760006.txt,FALSE,2013,,,,Clostridium difficile infection,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,mCRAMP,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22760006,22760006,22760006.txt,FALSE,2013,,,,Clostridium difficile infection,positive,,Wild Type,,,,,,mouse,,ileal loop,,,,,,,,,,,,,,,,,,mCRAMP,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22890996,22890996,22890996.txt,FALSE,2012,,,,Clostridium difficile,positive,,Germ Free,,,,,,mouse,,antibiotic-treated,,,,,,VPI 10463,,,,,,,,,,,,E. coli strains,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22890996,22890996,22890996.txt,FALSE,2012,,,,Clostridium difficile,positive,,Germ Free,,,,,,mouse,,antibiotic-treated,,,,,,"VPI 
 
 10463",,,,,,,,,,,,murine Lachnospiraceae isolate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/22895082,22895082,22895082.txt,FALSE,2012,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,viable S. thermophilus,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,probiotic,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,probiotic,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,epidermal growth factor,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,epidermal growth factor,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,ampicillin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,ampicillin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,lansoprazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,lansoprazole,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,cyclosporin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23183468,23183468,23183468.txt,FALSE,2012,,,,"Clostridium 
 
 difficile associated disease",positive,,BALB/c,,,,,,mouse,,,,,,,,,,,,,,,,,,,,cyclosporin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23420906,23420906,23420906.txt,FALSE,2013,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,CamSA,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23598380,23598380,23598380.txt,FALSE,2014,,,,Clostridium difficile.,positive,,C57BL/6,,,,,,mouse,,antibiotic(s),,,,,,,,,,,,,,,,,,calf IAP (cIAP),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23897615,23897615,23897615.txt,FALSE,2013,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"Antibody 
 
 neutralization of CXCL1 and CXCL2",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/23995682,23995682,23995682.txt,FALSE,2013,,,,Clostridium difficile,positive,,gnotobiotic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"sialidase-deficient mutant of 
 
 Bacteroides thetaiotaomicron",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24278446,24278446,24278446.txt,FALSE,2013,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,P2Y6 receptor antagonists (MSR2578),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24287693,24287693,24287693.txt,FALSE,2014,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,. difficile 027,,,,,,,,,,,,Thuricin CD,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24683195,24683195,24683195.txt,FALSE,2014,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,epidemic 027 strain,,,,,,,,,,,,"tetravalent, and bispecific antibody composed of 2 heavy-chain-only VH (VHH) binding domains against both TcdA and TcdB (designated ""ABA"")",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24828432,24828432,24828432.txt,FALSE,2014,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,B. subtilis,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24837414,24837414,24837414.txt,FALSE,2014,,,,C. difficile infection (CDI),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"5-nitro-1,10-phenanthroline (5-NP)",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24856984,24856984,24856984.txt,FALSE,2014,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,L. acidophilus GP1B cell extract,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24856984,24856984,24856984.txt,FALSE,2014,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,L. acidophilus GP1B,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/24890599,24890599,24890599.txt,FALSE,2014,,,,Clostridium difficile infections,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Amixicile,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25045999,25045999,25045999.txt,FALSE,2014,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,Cefoperazone-treated,,,,,,strain 630,,,,,,,,,,,,monoclonal antibody (mAb) against GM-CSF,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25327211,25327211,25327211.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"anti-IL-22, anti-CD160 or a combination of the two",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25399934,25399934,25399934.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,ceftriaxone,,,,,,VPI 10463,,,,,,,,,,,,monoclonal antibodies against Gr-1 or TNF-,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25805733,25805733,25805733.txt,FALSE,2015,,,,Clostridium difficile,positive,,,,,,,,mouse,,antibiotic-induced,,,,,,,,,,,,,,,,,,Av-CD291.2,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/25924765,25924765,25924765.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,3-MAb combination,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/2610698,2610698,2610698.txt,FALSE,1989,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"arginine specific reagent 1,2-cyclohexanedione",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26169403,26169403,26169403.txt,FALSE,2015,,,,C. difficile infection (CDI),positive,,C57BL/6,,,,,,mouse,,antibiotic-induced,,,,,,,,,,,,,,,,,,"5-(3-(4-fluorophenyl)butyl)-7,8-dimethylpyrido[3,4-b]quinoxaline-1,3(2H,5H)-dione (5FDQD)",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26181795,26181795,26181795.txt,FALSE,2015,,,,C. difficile,positive,,C57BL/6,,,,,,mouse,,,,,,,,VPI10463,,,,,,,,,,,,defined diet with either 20% protein or 2% protein,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26392484,26392484,26392484.txt,FALSE,2015,,,,,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"prophage lysin identified from a C. difficile strain, CD630, which we named PlyCD",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26400909,26400909,26400909.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,ebselen,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26556797,26556797,26556797.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Epigallocatechin gallate (EGCG),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26573738,26573738,26573738.txt,FALSE,2015,,,,Clostridium difficile,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,combination of two strains of engineered L. paracasei BL23 expressing two neutralizing anti-TcdB VHH fragments (VHH-B2 and VHH-G3),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26643348,26643348,26643348.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Bacteriophage (phage) therapy,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26643348,26643348,26643348.txt,FALSE,2015,,,,Clostridium difficile infection,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Bacteriophage (phage) therapy,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26655716,26655716,26655716.txt,FALSE,2016,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"insect 
 
 peptide CopA3",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/26809801,26809801,26809801.txt,FALSE,2016,,,,Clostridium difficile,positive,,,,,,,,mouse,,toxin A-induced,,,,,,,,,,,,,,,,,,potassium acetate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27067323,27067323,27067323.txt,FALSE,2016,,,,Clostridium difficile infections,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,trifluoperazine (TFP),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27143131,27143131,27143131.txt,FALSE,2016,,,,Clostridium difficile,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Kibdelomycin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27189122,27189122,27189122.txt,FALSE,2016,,,,Clostridium difficile,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Ramizol,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27280500,27280500,27280500.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,C57BL/6,,,,,,mouse,,,,,,,,,,,,,,,,,,,,indole-3-carbinol (I3C),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27280500,27280500,27280500.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,C57BL/6,,,,,,mouse,,,,,,,,,,,,,,,,,,,,indole-3-carbinol (I3C),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27280500,27280500,27280500.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,AHR,,,,,,mouse,,,,,,,,,,,,,,,,,,,,indole-3-carbinol (I3C),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27280500,27280500,27280500.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,AHR,,,,,,mouse,,,,,,,,,,,,,,,,,,,,indole-3-carbinol (I3C),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27280500,27280500,27280500.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,AHR null,,,,,,mouse,,,,,,,,,,,,,,,,,,,,indole-3-carbinol (I3C),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27280500,27280500,27280500.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,AHR null,,,,,,mouse,,,,,,,,,,,,,,,,,,,,indole-3-carbinol (I3C),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,hamster,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdA (CANmAbA4),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,hamster,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdB (CANmAbB4 and CANmAbB1),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,hamster,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdA (CANmAbA4),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,hamster,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdB (CANmAbB4 and CANmAbB1),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,mouse,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdA (CANmAbA4),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,mouse,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdB (CANmAbB4 and CANmAbB1),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,mouse,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdA (CANmAbA4),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27336843,27336843,27336843.txt,FALSE,2016,,,,Clostridium difficile (C. difficile) infection,positive,,,,,,,,mouse,,"toxin challenge 
 
 model",,,,,,,,,,,,,,,,,,anti-TcdB (CANmAbB4 and CANmAbB1),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27413067,27413067,27413067.txt,FALSE,2016,,,,Clostridium difficile infection,positive,,gnotobiotic,,,,,,piglets,,,,,,,,,,,,,,,,,,,,VNA2-Tcd,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27413067,27413067,27413067.txt,FALSE,2016,,,,Clostridium difficile infection,positive,,gnotobiotic,,,,,,mouse,,,,,,,,,,,,,,,,,,,,VNA2-Tcd,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27413067,27413067,27413067.txt,FALSE,2016,,,,Clostridium difficile infection,positive,,gnotobiotic,,,,,,hamsters,,,,,,,,,,,,,,,,,,,,VNA2-Tcd,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/27999606,27999606,27999606.txt,FALSE,2016,,,,Clostridium difficile associated diarrhea,positive,,C57BL/6,,,,,,mouse,,exposure to antimicrobial mixture.,,,,,,VPI 10463,,,,,,,,,,,,Traditional Chinese medicine QPYF,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28173695,28173695,28173695.txt,FALSE,2017,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"Periplanetasin-2 (Peri-2, YPCKLNLKLGKVPFH)",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28484429,28484429,28484429.txt,FALSE,2017,,,,,positive,,C57BL/6,,,,,,mouse,,antibiotic,,,,,,ATCC 1870,,,,,,,,,,,,carvacrol,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28497217,28497217,28497217.txt,FALSE,2018,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"Mixture of Potential Probiotic Strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28580440,28580440,28580440.txt,FALSE,2016,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"Enterococcus 
 
 faecium",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28584146,28584146,28584146.txt,FALSE,2017,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Aztreonam,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28584146,28584146,28584146.txt,FALSE,2017,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,piperacillin-tazobactam,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28761936,28761936,28761936.txt,FALSE,2017,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28764868,28764868,28764868.txt,FALSE,2017,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,lanthionine synthetase C-like 2 (LANCL2),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28811642,28811642,28811642.txt,FALSE,2017,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Fe3-O4 nanoparticles.,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28856119,28856119,28856119.txt,FALSE,2017,,,,C. difficile,positive,,C57BL/6,,,,,,mouse,,initiation,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28856119,28856119,28856119.txt,FALSE,2017,,,,C. difficile,positive,,C57BL/6,,,,,,mouse,,initiation,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28856119,28856119,28856119.txt,FALSE,2017,,,,C. difficile,positive,,C57BL/6,,,,,,mouse,,recurrence,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28856119,28856119,28856119.txt,FALSE,2017,,,,C. difficile,positive,,C57BL/6,,,,,,mouse,,recurrence,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/28949065,28949065,28949065.txt,FALSE,2017,,,,,positive,,,,,,,,mouse,,toxin A-induced,,,,,,,,,,,,,,,,,,"Periplanetasin-4 
 
 (Peri-4),",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29140433,29140433,29140433.txt,FALSE,2018,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,interleukin-27 (IL-27),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29140433,29140433,29140433.txt,FALSE,2018,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,WT,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29615987,29615987,29615987.txt,FALSE,2018,,,,C. difficile,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,OG253,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,Candida albicans,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,Candida albicans,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,IL-17A,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,IL-17A,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,Candida albicans,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,Candida albicans,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,IL-17A,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29667487,29667487,29667487.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,IL-17A,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29686297,29686297,29686297.txt,FALSE,2018,,,,Clostridium difficile,positive,,,,,,,,mouse,,antibiotic-induced,,,,,,,,,,,,,,,,,,"diet containing a 
 
 complex mixture of MACs",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29686297,29686297,29686297.txt,FALSE,2018,,,,Clostridium difficile,positive,,,,,,,,mouse,,antibiotic-induced,,,,,,,,,,,,,,,,,,simplified diet containing inulin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29768720,29768720,29768720.txt,FALSE,2018,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,bis-cyclic guanidine compounds,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29894469,29894469,29894469.txt,FALSE,2018,,,,C. difficile infection (CDI),positive,,Golden Syrian,,,,,,hamster,,,,,,,,,,,,,,,,,,,,OG716,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/29950381,29950381,29950381.txt,FALSE,2018,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,antibiotic,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30392779,30392779,30392779.txt,FALSE,2018,,,,Clostridium difficile infection.,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,11d,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30531960,30531960,30531960.txt,FALSE,2018,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,niclosamide,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30645630,30645630,30645630.txt,FALSE,2019,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,antibiotics,,,,,,,,,,,,,,,,,,C. albicans,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30687250,30687250,30687250.txt,FALSE,2019,,,,C. difficile infection (CDI),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"designated LHD, is composed of two parts connected by a 3-repeating unit linker ""(GGGGS)3"": the catalytic domain of a lysin protein from a C. difficile bacteriophage phiC2 (LCD), and the functional domain of a human defensin protein HD5",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30816855,30816855,30816855.txt,FALSE,2019,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,E. coli expressing highly active BSH,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30901686,30901686,30901686.txt,FALSE,2019,,,,Clostridioides (formerly Clostridium) difficile,positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,biaryl peptidomimetics 28 and 67,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/30995474,30995474,30995474.txt,FALSE,2019,,,,Clostridium difficile.,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Butyrate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31233493,31233493,31233493.txt,FALSE,2019,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,DLD-4,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31642901,31642901,31642901.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,auranofin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31793403,31793403,31793403.txt,FALSE,2020,,,,C. difficile disease,positive,,,,,,,,mouse,,clindamycin,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31793403,31793403,31793403.txt,FALSE,2020,,,,C. difficile disease,positive,,,,,,,,mouse,,clindamycin,,,,,,,,,,,,,,,,,,,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31793629,31793629,31793629.txt,FALSE,2020,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Anti-MIP-1  neutralizing antibody,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31838076,31838076,31838076.txt,FALSE,2020,,,,,positive,,,,,,,,mouse,,antibiotics,,,,,,CD027,,,,,,,,,,,,lactotrehalose,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31838076,31838076,31838076.txt,FALSE,2020,,,,,positive,,,,,,,,mouse,,antibiotics,,,,,,CD027,,,,,,,,,,,,trehalose,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31876919,31876919,31876919.txt,FALSE,2020,,,,Clostridium difficile infections,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,short-chain fatty acid acetate,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31887433,31887433,31887433.txt,FALSE,2020,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,PCR ribotype 027,,,,,,,,,,,,Pediococcus acidilactici SPM138 (SPM138),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31907198,31907198,31907198.txt,FALSE,2020,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,ampicillin-resistant bacteria,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31907988,31907988,31907988.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,pregnenolone 16-carbonitrile (PCN),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31909964,31909964,31909964.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,DHP,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31909964,31909964,31909964.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,non-DHP molecules,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31915217,31915217,31915217.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,cefoperazone,,,,,,,,,,,,,,,,,,Xanthan gum,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31915217,31915217,31915217.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,antibiotic cocktail,,,,,,,,,,,,,,,,,,Xanthan gum,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31915217,31915217,31915217.txt,FALSE,2020,,,,C. difficile,positive,,,,,,,,mouse,,cefoperazone,,,,,,,,,,,,,,,,,,Xanthan gum,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/31915217,31915217,31915217.txt,FALSE,2020,,,,C. difficile,positive,,,,,,,,mouse,,antibiotic cocktail,,,,,,,,,,,,,,,,,,Xanthan gum,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32047064,32047064,32047064.txt,FALSE,2020,,,,C. difficile,positive,,,,,,,,mouse,,antibiotic-induced,,,,,,R20291,,,,,,,,,,,,diets,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32084340,32084340,32084340.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,Halicin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32156803,32156803,32156803.txt,FALSE,2020,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,recombinant bacteriophage expressing bacterial genome-targeting CRISPR RNAs,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32156806,32156806,32156806.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,amoxapine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32156806,32156806,32156806.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,doxapram,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32156806,32156806,32156806.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,murine,,,,,,,,,,,,,,,,,,,,trifluoperazine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32190927,32190927,32190927.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,intestinal loops,,,,,,,,,,,,,,,,,,-defensin-1,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32205405,32205405,32205405.txt,FALSE,2020,,,,Clostridioides difficile infection,positive,,,,,,,,murine,,,,,,,,R20291,,,,,,,,,,,,ursodiol,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32382070,32382070,32382070.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,auranofin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32483557,32483557,32483557.txt,FALSE,2020,,,,Clostridium difficile infection,positive,,,,,,,,hamster,,antibiotic-induced,,,,,,,,,,,,,,,,,,ebselen,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32635220,32635220,32635220.txt,FALSE,2020,,,,,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Candida albicans,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32635220,32635220,32635220.txt,FALSE,2020,,,,,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,olive oil,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,Clostridiodes difficile infection (CDI),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,high-fat diet (HFD)-fed,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,Clostridiodes difficile infection (CDI),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,high-fat diet (HFD)-fed,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,Clostridiodes difficile infection (CDI),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Obeticholic acid,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,Clostridiodes difficile infection (CDI),positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Obeticholic acid,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,high-fat diet (HFD)-fed,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,high-fat diet (HFD)-fed,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Obeticholic acid,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32811993,32811993,32811993.txt,FALSE,2021,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Obeticholic acid,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32841647,32841647,32841647.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,TLR9 antagonist,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/32960605,32960605,32960605.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,HSGN-218,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33072047,33072047,33072047.txt,FALSE,2020,,,,Clostridioides difficile infection,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,OraCAb,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33115949,33115949,33115949.txt,FALSE,2020,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,probiotic Saccharomyces boulardii to constitutively secrete a single tetra-specific antibody,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33508620,33508620,33508620.txt,FALSE,2021,,,,Clostridioides difficile infection,positive,,,,,,,,mouse,,,,,,,,BI/NAP1/027,,,,,,,,,,,,Bacteroides thetaiotaomicron (B. thetaiotaomicron),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33597149,33597149,33597149.txt,FALSE,2021,,,,Clostridioides difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Clostridium butyricum MIYAIRI588 (CBM588),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33649048,33649048,33649048.txt,FALSE,2021,,,,Clostridioides difficile,positive,,C57BL/6,,,,,,mouse,,,,,,,,,,,,,,,,,,,,antibody-mediated blockade of IL-10 signaling,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33734244,33734244,33734244.txt,FALSE,2021,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,Pediococcus pentosaceus Li05 (Li05),,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/33734244,33734244,33734244.txt,FALSE,2021,,,,Clostridium difficile infection,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,encapsulated Li05,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/3909315,3909315,3909315.txt,FALSE,1985,,,,,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Aztreonam,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/3909315,3909315,3909315.txt,FALSE,1985,,,,,positive,,,,,,,,hamster,,,,,,,,,,,,,,,,,,,,Clostridium difficile-induced,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/6658814,6658814,6658814.txt,FALSE,1983,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,beta-naphthoflavone,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/6673499,6673499,6673499.txt,FALSE,1983,,,,Clostridium difficile,positive,,,,,,,,mouse,,intestinal loops,,,,,,,,,,,,,,,,,,chlorpromazine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/6673499,6673499,6673499.txt,FALSE,1983,,,,Clostridium difficile,positive,,,,,,,,mouse,,toxin A,,,,,,,,,,,,,,,,,,chlorpromazine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7399686,7399686,7399686.txt,FALSE,1980,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,antitoxin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7508124,7508124,7508124.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rats,,ileal loop,,,,,,,,,,,,,,,,,,"CP-96,345",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/759263,759263,759263.txt,FALSE,1979,,,,Clostridium difficile,positive,,,,,,,,,,clindamycin,,,,,,,,,,,,,,,,,,C. sordellii antitoxin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/759263,759263,759263.txt,FALSE,1979,,,,Clostridium difficile,positive,,,,,,,,,,clindamycin,,,,,,,,,,,,,,,,,,C. sordellii antitoxin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,indomethacin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,ketanserin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,ketanserin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,tropisetron,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,tropisetron,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,Atropine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,Atropine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,hexamethonium,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7909488,7909488,7909488.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rats,,jejunum,,,,,,,,,,,,,,,,,,hexamethonium,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,lidocaine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,ileum,,,,,,,,,,,,,,,,,,lidocaine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,hexamethonium,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,ileum,,,,,,,,,,,,,,,,,,hexamethonium,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,atropine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,ileum,,,,,,,,,,,,,,,,,,atropine,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A,,,,,,,,,,,,,,,,,,capsaicin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/7915699,7915699,7915699.txt,FALSE,1994,,,,Clostridium difficile,positive,,,,,,,,rat,,ileum,,,,,,,,,,,,,,,,,,capsaicin,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8395445,8395445,8395445.txt,FALSE,1993,,,,Clostridium difficile,positive,,,,,,,,rat,,toxin A-induced enterotoxicity in rat ileum.,,,,,,,,,,,,,,,,,,ketotifen,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8690209,8690209,8690209.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rats,,ileal loop,,,,,,,,,,,,,,,,,,Synsorb 90,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8690209,8690209,8690209.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rats,,ileal loop,,,,,,,,,,,,,,,,,,Synsorb 83,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8690209,8690209,8690209.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rats,,ileal loop,,,,,,,,,,,,,,,,,,Chromosorb P,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/8698855,8698855,8698855.txt,FALSE,1996,,,,Clostridium difficile,positive,,,,,,,,rabbit,,ileal loop,,,,,,,,,,,,,,,,,,anti-SI IgG,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9114070,9114070,9114070.txt,FALSE,1997,,,,Clostridium difficile,positive,,,,,,,,rats,,,,,,,,,,,,,,,,,,,,"CP-96,345",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9191992,9191992,9191992.txt,FALSE,1997,,,,C. difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,20% fermentable fibre,,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9421310,9421310,9421310.txt,FALSE,1997,,,,Clostridium difficile,positive,,,,,,,,mouse,,ampicillin,,,,,,,,,,,,,,,,,,"AM-1155, a 6-fluoro-8-methoxy quinolone",,,,,,FALSE
https://pubmed.ncbi.nlm.nih.gov/9558284,9558284,9558284.txt,FALSE,1998,,,,Clostridium difficile,positive,,,,,,,,mouse,,,,,,,,,,,,,,,,,,,,"P-receptor antagonist (CP-96,345)",,,,,,FALSE
